Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 18, 2026.

Researching glutamate – induced cytotoxicity in different cell lines: a comparative/collective analysis/study

Aristeidis A. Kritis, Eleni G. Stamoula, Krystallenia A. Paniskaki and 1 more

Frontiers in Cellular Neuroscience · 2015 · Review

doi:10.3389/fncel.2015.00091

Abstract

Although glutamate is one of the most important excitatory neurotransmitters of the central nervous system, its excessive extracellular concentration leads to uncontrolled continuous depolarization of neurons, a toxic process called, excitotoxicity. In excitotoxicity glutamate triggers the rise of intracellular Ca(2+) levels, followed by up regulation of nNOS, dysfunction of mitochondria, ROS production, ER stress, and release of lysosomal enzymes. Excessive calcium concentration is the key mediator of glutamate toxicity through over activation of ionotropic and metabotropic receptors. In addition, glutamate accumulation can also inhibit cystine (CySS) uptake by reversing the action of the CySS/glutamate antiporter. Reversal of the antiporter action reinforces the aforementioned events by depleting neurons of cysteine and eventually glutathione's reducing potential. Various cell lines have been employed in the pursuit to understand the mechanism(s) by which excitotoxicity affects the cells leading them ultimately to their demise. In some cell lines glutamate toxicity is exerted mainly through over activation of NMDA, AMPA, or kainate receptors whereas in other cell lines lacking such receptors, the toxicity is due to glutamate induced oxidative stress. However, in the greatest majority of the cell lines ionotropic glutamate receptors are present, co-existing to CySS/glutamate antiporters and metabotropic glutamate receptors, supporting the assumption that excitotoxicity effect in these cells is accumulative. Different cell lines differ in their responses when exposed to glutamate. In this review article the responses of PC12, SH-SY5Y, HT-22, NT-2, OLCs, C6, primary rat cortical neurons, RGC-5, and SCN2.2 cell systems are systematically collected and analyzed.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 18, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

Glutamate is one of the main excitatory neurotransmitters of the CNS, contributing to normal neural transmission, development, differentiation, and plasticity. However, excessive extracellular glutamate concentration can lead to uncontrolled continuous depolarization of neurons, a toxic process called, excitotoxicity, leading eventually to neuronal death. Excitotoxicity is associated with many neurodegenerative conditions such as Huntington’s disease, Alzheimer’s disease, lateral amyotrophic sclerosis, Parkinson’s disease and stroke or traumatic brain injury.

Glutamate both in neurons and glial cells is synthesized through the tricarboxylic acid cycle and additionally in neurons by the glutamate–glutamine cycle, where it is accumulated in vesicles for future release. Glutamate is ligand to post-synaptic either iGluRs or mGluRs. Under pathological stimuli, glutamate release is excessive; GluR over activation ensues, resulting in an augmented intracellular Ca2+ influx.

Increased intracellular Ca2+ concentration disrupts calcium homeostasis and initiates a cascade of signaling pathways, leading to up regulation of nNOS, dysfunction of mitochondria, deregulation of oxidative phosphorylation, ROS production, ER stress, and release of lysosomal enzymes. Excessive calcium concentration is the key mediator of glutamate toxicity through over activation of ionotropic and metabotropic receptors. In addition, glutamate accumulation can also inhibit CySS uptake by reversing the action of the CySS/glutamate antiporter (Xc-). Reversal of Xc- action reinforces the aforementioned events by depleting neurons of CySS and eventually GSH, leading to free radical accumulation. In the absence of glutamate receptors, glutamate toxicity can occur through this antiporter promoting a Ca2+ independent, non-receptor mediated oxidative glutamate toxicity. Glutamate exerts its toxic effects through molecular pathways, which lead to neurodegeneration and cell death, for reviews see.

In the last three decades various cell models have been used in excitotoxicity studies and different pathways pertaining to cell survival and/or cell death have been reported to be triggered in each cell line. This review summarizes the effect of excitotoxicity on the homeostasis of the cellular organelles, the cell signaling pertaining to survival and cell death and focuses on the cell lines that have been used as models for the study of the excitotoxicity.

Glutamate Release and Reuptake: the Glutamate–Glutamine Cycle and Xc-

During neurotransmission, glutamate is released by depolarization of pre-synaptic membranes via a Ca2+-dependent process, involving VDCCs. VDCCs are of N, P/Q, R, and L-type characterized by their subunit composition and their inhibition by specific toxins. They mediate glutamate synaptic release in CNS and their distribution among nerve terminals varies. In certain terminals, only one type is present, while others possess more than one.

Neurotransmission is ended within millisecond by efficient glutamate reuptake via Na+-dependent high affinity glutamate membrane EAATs: EAAT1 (GLAST), EAAT2 (GLT1), EAAT3 (EAAC1), EAAT4, and EAAT5. EAAT2 is commonly expressed in glial cells and EAAT3 in neurons. EAAT2 is believed to play the main role in regulating extracellular glutamate concentration. In glial cells reuptaken glutamate is converted to glutamine by glutamine synthetase thus ending neurotransmission, offering neuroprotection and preventing excitotoxicity. Glial glutamine is taken up into the presynaptic neuron via Na+-dependent glutamine uptake systems, where it is converted to glutamate by glutaminase thus completing the glutamate–glutamine cycle (;;; Figure 1).

The Ca2+-independent glutamate release is attributed to reverse action of the aforementioned glutamate transporters. Reverse action of glutamate transporters can occur during depolarization, when the Na+ and K+ gradients are diminished possibly contributing to the regulation of glutamatergic neurotransmission. In hypoxia reduced expression of EAAT1 and 2 contributes to increase extracellular glutamate concentration leading to neuronal overexcitation and excitotoxicity.

Another important molecule modulating both extra- and intra-cellular glutamate concentrations is the XC-. This is of added importance for the nervous system since L-cystine taken up by the cells can be used for GSH synthesis and protection from oxidative insults, for a review see. Excessive extracellular glutamate concentration blocks the uptake of CySS which is essential for biosynthesis of GSH. GSH depletion influences the capacity of cells to scavenge free radicals, a fact that makes cells vulnerable to secondary events such as accumulation of ROS and alteration in Ca2+ homeostatic mechanisms resulting in cell death.

Glutamatergic Neurotransmition: the Glutamate Receptors

There are two types of glutamate receptors categorized according to their function. iCluRs functioning upon binding of glutamate as ion channels and mGluRs. mGluRs are G protein coupled receptors, coupled to their associated ion channels via a second messenger cascade. iGluRs are named after their respective agonist, NMDARs, AMPARs, and KARs. They are multimeric assemblies of different protein subunits that form homo or heteromeric complexes of varying subunit combination, resulting to multiple types of ion channels with different properties. iGluRs mediate fast synaptic transmission and are broadly classified in two classes as NMDA and non-NMDA receptors.

N-methyl-D-aspartate receptors are complex structures able to bind glutamate, glycine, Mg2+, Zn2+, and polyamines. Composed from seven subunits (one NR1, four NR2, and two NR3), their function is determined by the combination of NR1 and NR2 subunits. NMDARs form channels that are more permeable to Ca2+ than Na+ and K+. Upon binding of glutamate the magnesium ions, blocking the ion channel, are released and consequently the ion channel is activated allowing the influx of the aforementioned ions into the cytoplasm. Kainate and AMPA receptors interact only with glutamate and their specific agonists, and their associated channels are more permeable to Na+ and K+ than Ca2+(; Figure 2).

Metabotropic glutamate receptors are G-protein coupled receptors and trigger a second messenger cascade. They are found both at the pre- and post-synaptic neurons, but also subunits of metabotropic receptors are expressed in microglia (;; Figure 2).

There are eight different types of mGluRs (mGluR1 to mGLUR8) and are classified to three groups according to their structure and physiological activity (groups I, II, and III). Group I (mGluR 1 and 5) are mainly post-synaptic receptors coupled to a Gq heterotrimeric G protein. Upon binding of glutamate, PLC is activated and 1,4,5-inositol triphosphate is produced initiating multiple intracellular responses. Evidence is presented for PKC-dependent and independent pathways potentiating the NMDA responses by mGluRs. Groups II and III are coupled to Gi/G0 thus inhibiting the action of adenylate cycle and reducing intracellular cAMP levels.

Pertaining to excitotoxicity, NMDARs play the most important role as larger quantities of Ca2+ ions can be moved through them. The role of kainate and AMPA receptors is also important as it has been shown that their activation is directly related to the ER stress. Activation of the iGluRs creates a depolarization (excitatory post-synaptic current) and depending on the number of the receptors that are activated, this current, can lead to an action potential. This current is also essential to the function of NMDARs since it can lift their voltage dependent Mg2+ block.

Of the mGluRs class I is positively connected with excitotoxicity by modulating the NMDA receptor activity while classes II and III are negatively related to the phenomenon, through the suppression of intracellular cAMP levels inhibiting the export of potentially neurotoxic glutamate from microglia offering a neuroprotective role.

Glutamate Receptors and Cell Death

Both iGluRs and mGluRs mediate the excitotoxic insult via distinct, but not independent pathways. However, key players in the initiation of the exitoxic insult are the iCluRs. The elevated Ca2+ concentration upregulates the activity of nNOS, contributes to mitochondrial activity deregulation and ER stress, leading to cell membrane depolarization and dysfunction of intracellular organelles. As iGluRs are permeable not only to Ca2+ but also to Na+ and K+, their activation leads to depolarization of the cell membrane and osmotic inflow of water.

N-methyl-D-aspartate receptor activity can be modulated by mGluRs. mGluRs do not participate directly in the excitotoxic insult, but rather seem to modulate it. NMDARs can be up regulated by Src kinase mediated tyrosine phosphorylation, leading to increased channel permeability. Group I are positively coupled via a Gq-protein to PLC, resulting in the release of Ca2+ from intracellular stores. Augmented intracellular Ca2+ concentration can lead to the sequential activation of PKC, Pyk2 and Src, resulting in the tyrosine phosphorylation of NMDARs. NMDAR phosphorylation via Src family results in its up regulation and increases open channel probability. PKC and mGluR 1 potentiate NMDARs currents not only by increased open channel probability but also by recruiting new channels to the membrane in cooperation with cytoskeletal proteins.

Both mGluR1 and mGluR5 lead to the potentiation of NMDA receptor currents via Src-dependent mechanism. Alternatively others support that both mGluR1 and mGluR5 can interact with calmodulin in a calcium dependent manner, proposing that other molecules besides PKC may be responsible for the mGluR1 mediated activation of Pyk2/Src and the potentiation NMDARs currents (Figure 3). Group II (mGluR2 and 3) and III (mGluR4, 6, 7, and 8) are coupled to Gi/G0 proteins leading to inhibition of adenylate cyclase decreasing the levels of cAMP in the cytoplasm. Subunits of metabotropic receptors (groups I, II, and III) are also expressed in microglia. Groups II and III through the suppression of intracellular cAMP levels inhibit the export of potential neurotoxic glutamate from microglia offering a neuroprotective role.

Recently it is reported that calpains, proteases activated by elevated intracellular calcium concentration, form a negative feedback loop for controlling calcium influx, by means of cleavage and subsequent inactivation of glutamate receptors. This feedback loop may contribute to a neuroprotective effect against the excitotoxic insult (;; Figure 3).

nNOS Up Regulation and Cell Death the Key Player

N-methyl-D-aspartate receptors are linked to neuronal nitric oxide synthase (nNOS), and therefore their activation leads to production of toxic NO-levels. NMDARs and nNOS are connected by the post-synaptic density protein PSD-95. Over activation of NMDARs under excitotoxic conditions provokes Ca2+ influx which results in activation of nNOS via calmodulin.

More recently, NO has been shown to interfere with neurotoxicity through an interaction with GAPDH. GAPDH/Siah 1(an E3 ubiquitin ligase) pathway is a novel pathway that links NO to a form of apoptotic-like death. Increased intracellular concentration of NO causes S-nitrosylation of GAPDH which triggers GAPDH binding to Siah 1. GAPDH/Siah1 complex is translocated to the nucleus resulting in the transcription of the proapoptotic factor p53. Activation of nuclear proteins such as p53 results in pyknotic nucleus and other morphological characteristics that indicate apoptotic death. Moreover, GAPDH plays a pivotal role in glycolysis and it is possible that GAPDH-NO interaction leads to loss of function and energy failure.

Glutamate excitotoxicity causes Ca2+ mediated NO production leading to mitochondrial dysfunction resulting in superoxide production, which is released via voltage dependent anion channels into the cytosol. NO-superoxide interaction can produce peroxynitrite an oxidative molecule that can cause lipid peroxidation, direct DNA damage and protein dysfunction. Peroxynitrite has many deleterious effects, such as the inhibition of mitochondrial electron transport chain, cytochrome c normal activity as well as of superoxide dismutase via protein nitration. These facts can provoke caspase mediated cell death and an eventual apoptotic cell death (; Figure 3).

In addition NO activated soluble guanylate cyclase increase levels of cGMP. The three principal targets of cGMP are protein kinase G (PKG), cyclic-nucleotide gated channels (CNGCs), and cyclic-nucleotide phosphodiesterase (PDE). Of these, PKG provides the broadest means for controlling ion-channel function modulating this way neuronal excitability.

Deregulation of Intracellular Organelles-Mitochondria, ER, Lysosomes

Deregulation of cell signaling due to excitotoxicity leads to altered function of intracellular organelles. Mitochondria, ER, and lysosomes are mostly affected by the increased Ca2+ influx, and their degeneration plays a pivotal role in neuronal death.

Mitochondria produce not only ATP, but also ROS and regulate Ca2+ homeostasis. Normally Ca2+ intake controls the activity of three dehydrogenases: pyruvate, isocitrate and ketoglutaric acid dehydrogenase, as well as ATP synthase. However, the increased influx of Ca2+ leads to mitochondrial Ca2+ overload and depolarization of mitochondrial membrane. The consequences of this overload is: (a) the activation of mitochondrial permeability transition pore, (b) phospholipase A2 and xanthine oxidase up-regulation, (c) inhibition of respiratory chain enzymes and (d) deactivation of catalase, superoxide dismutase, and GSH peroxidase. The deregulation of respiratory chain enzymes firstly decreases ATP synthesis and secondly overproduces ROS, which cannot be neutralized by the cell. ATP depletion leads to neuronal bioenergetic failure and neurodegeneration. ROS react with biological molecules (lipids, proteins, nucleic acids, carbohydrates), producing new oxidative species, which trigger oxidative chain reactions of other macromolecules. In this way ROS bind to DNA evoking its fragmentation. Mitochondrial DNA, which lacks on histones, is especially vulnerable to ROS oxidation. The above in combination to PLC up-regulation, lead to membrane lipid peroxidation with the consequent membrane destabilization.

The result of all these factors is synaptic dysfunction, impaired neuronal plasticity and cell death via apoptosis, necrosis and/or autophagy. A central player in the potential driven mitochondrial Ca2+ uptake, is the mitochondrial Ca2+ uniporter (MCU), whose gene has been recently characterized. In excitotoxicity Ca2+ uniporter acts as a mediator of death-signal, induced by loss of mitochondrial membrane potential (MMP), but can also serve a pro-survival role through neuroprotective Ca2+ signaling stemming from synaptic activity (; Figure 3).

Endoplasmic reticulum is an important cell organelle responsible for correct folding and sorting, translation, and post-translational modification of proteins and serves as an intracellular Ca2+ storage. ER is functionally connected to mitochondria through intracellular Ca2+ flow between them. ER functions can be disturbed by different insults such as accumulation of unfolded proteins and changes in Ca2+ homeostasis. Overstimulation of AMPA receptors results in inordinate Ca2+ concentration which leads to activation of ryanodine receptors (RyRs) located in ER.

Activation of RyRs in conjunction with accumulation of misfolded proteins and depletion of endoplasmic Ca2+ storage, results in ER dysfunction (ER-stress). Cell response to ER-stress is called unfolded protein response (UPR; ) and consists of two repair mechanisms: activation of proteasome and ubiquitinization of dysfunctional proteins and induced expression of molecular chaperones.

Lysosomes are organelles which contain hydrolytic enzymes (proteases, nucleases, and lipases) necessary for intracellular digestion. Under excitotoxic conditions the number of lysosomes is increased because of enhanced induction of autophagy. It has been reported that NMDARs channeling in rat cerebellar granule neurons in culture, increased phaghosomes and their conjugation with lysosomes. Moreover, several lines of evidence support a cross-talk between apoptosis and autophagy, since certain caspases can directly or indirectly activate cathepsins. Mitochondrial dysfunction leads eventually to activation of caspases which results in the release of cathepsins. The latter activates authophagy through release of lysosomal contents into the cytoplasm.

Autophagy is a natural cell function in CNS since it plays a pivotal role in neuroprotection. It has been reported that traumatic brain injury is followed by enhanced autophagic processes. Activation of NR2B via CaMKII kinases contributes to the release of Beclin-1 which induces autophagy, while NR2B antagonists prevent excitotoxic-induced autophagy. Over activation of lysosomes and uncontrolled release of lysosomal enzymes caused by excitotoxicity contributes to neuronal death and brain pathology (; Figure 3).

Cell Lines Models Utilized for the Study of Glutamate-Induced Cytotoxicity

Based in bibliographic search we concluded that nine cell lines are widely used in researching in vitro excitotoxicity: PC12-rat pheochromocytoma, SH-SY5Y-human neuroblastoma, HT-22-immortalized mouse hippocampal cell line, Ntera /D1-NT-2 human teratocarcinoma, oligodendroglial lineage cells (OLCs), C6 -rat glioma, primary cortical rat neurons (PCRNs), RGC-5-mouse retinal ganglion cells, and SCN2.2 -hypothalamic suprachiasmatic nucleus (SCN) rat cell line. Below we summarize the methodology employed and the findings with respect to the signaling pathways activated in each cell line while researching excitotoxicity.

PC12

PC12 is a cell line derived from rat adrenal medulla pheochromocytoma, they synthesize dopamine and glutamate and can be induced to differentiate by NGF to a sympathetic phenotype expressing neurites and excitability. PC12 cell line has been extensively used as a tool for studying the function of neurons, neuronal differentiation, and neurotoxicity.

Glutamate exerts its toxic effects on PC12 in a dose and time dependent manner. Its toxic concentration varies between 0.01 and 10 mM while time varies from 30 min to 3-12-24-48 h of incubation.

Even though mRNA for NMDA receptor subunits is expressed by PC12 cells there are contradictory findings, reported in the literature, concerning the receptor functionality, and presence of receptor protein. According to only trace amounts of the receptor protein are present in PC12 cells and no functional NMDA-operated channels exist in this cells line. This has also been supported recently from in vitro findings in PC12 cell studies. On the other hand, others support both the presence and functionality of the NMDARs in PC12 cells (;;,,; Figure 3).

In addition to excitotoxicity, glutamate appears to exert a cytotoxic action at very high extracellular concentrations (5–10 mM; ). This glutamate-induced cytotoxicity is independent of NMDARs and is mediated through the inhibition of CySS uptake leading to depletion of GSH and oxidative glutamate toxicity (;; Figure 4 and Table 1).

The above two mechanisms of glutamate-mediated toxicity can act cooperatively on PC12 cell death, while other investigators support that cell death on PC12 is exclusively due to NMDARs over activation or inhibition of glu/cys antiporter without NMDAR implication. We propose that these conflicting reports can be attributed to researchers studying cell death triggered simultaneously by two different events: increased intracellular Ca2+ concentration and GSH depletion. At glutamate concentrations greater than 20 μM the Xc- antiporter begins the reverse CySS transport thus depriving the cells of their ROS inactivation potential.

In relation to the above, there are reports that excitotoxic cell death in PC12 cells, can be effected by apoptosis and/or necrosis, while others support a caspase independent calpain mediated cell death probably necroptosis by activation of AIF. Investigating hypoxia in a PC12 oxygen glucose deprivation model, showed that cathepsin D inhibition protects from cell death suggesting the implication of the autophagic processes. This is important in view of excitotoxicity following ischemic insults due to excessive cell death and uncontrolled release of glutamate.

Neuroprotective mechanisms of PC12 cells include the expression of GRP78, which suppresses oxidative stress and stabilizes Ca2+ homeostasis. Protein kinase B/Akt exhibits prosurvival and antiapoptotic activities and is involved in growth factor-mediated neuronal protection. Akt deactivation characterizes both caspase-dependent and -independent cell death. Additionally PI3K/Akt pathway may preferentially regulate both NGF and BDNF-mediated cell survival (; Table 2).

Human Neuroblastoma SH-SY5Y Cell Line

Human brain neuroblastoma SH-SY5Y differentiated cell line is derived from bone marrow and is extensively used as a model for the study of oxidative stress pertaining to neuronal death. SH-SY5Y cells exhibit many characteristics of dopaminergic neurons, they have the ability to synthesize dopamine and norepinephrine and they express dopamine transporter. Upon treatment with a variety of agents, including RA phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA; ), BDNF, dibutyryl cAMP, purine or staurosporine. SH-SY5Y cells are differentiated and exhibit neuronal like characteristics. This cell line serves as a neuronal model for Parkinson’s disease research.

Several studies in this cell line have detected the expression of both iCluRs and mGluRs, while others support that SH-SY5Y cells are deficient in NMDARs or that NMDARs have no function. support that increased cytoplasmic Ca2+ after glutamate treatment is independent of glutamate receptors (both NMDA and metabotropic) in SH-SY5Y cells. In this cell line glutamate induced cytotoxicity could be mediated by oxidative stress through CySS/glutamate antiporter, depletion of GSH, down regulation of SOD activity leading to apoptosis (oxidative glutamate toxicity; Figure 4 and Table 1).

Others use the SH-SY5Y cell line for investigating hypoxia employing protocol of oxygen glucose deprivation (OGD). Experimental evidence suggests that glutamate-induced apoptotic cell death involves the Rac-NADPH oxidase-mediated ROS formation in SH-SY5Y cells (; Table 2). One of the downstream targets of NADPH oxidase-derived superoxide radicals is the transcription factor NF-κB which regulates the expression of many genes involved in cell survival and inflammation. NF-κB is also a key factor in regulating NADPH oxidase expression and it is possible that there is a positive feedback loop in which NF-κB activation by oxidative stress leads to further radical production via NADPH oxidase.

HT-22 Immortalized Hippocampal Cell Line

HT-22 cell line is an immortalized mouse hippocampal cell line that is extensively used to study the non-receptor mediated oxidative glutamate toxicity. These cells lack iCluRs but are still sensitive to high concentrations of extracellular glutamate (Tables 1 and 2). Glutamate evokes oxidative death in HT22 in a time- and dose-dependent manner involving both necrotic and apoptotic processes. Recent data shows that glutamate induces mainly necrosis at early time points (before 12 h), but predominantly induces apoptosis at latter ones (12–24 h;; ). This toxicity is exerted by reduction in GSH production through the CySS/glutamate exchanger (;;;;;;; Figure 4). Mitochondrial oxidative stress and dysfunction are important preceding events promoting glutamate induced cell death in HT-22. Treatment with glutamate (i) alters MMP (ii) induces mitochondrial cytochrome c release (iii) release of mitochondrial AIF, which catalyzes DNA fragmentation and apoptosis. Oxidative stress activates the c-jun N-terminal kinase (JNK) and p38 mitogen activated kinase pathways via apoptosis signal regulating kinase-1 (ASK1), leading to apoptosis.

The exact mechanism of glutamate induced excitotoxicity is not clear, and some believe that this process may be mediated through the activation of MAPKs and inhibition of the PI3K/Akt pathway.

In vitro evidence support that glutamate treated HT22 cells, exhibit a delayed and persistent activation of ERKs which contributes to oxidative toxicity. In HT-22 cell line glutamate significantly up regulates the phosphorylation of ERK1/2 while decreasing Erk3. Furthermore glutamate treated HT22 increase intracellular Ca2+ levels by means of activation of cobalt-sensitive channels. It is noteworthy that cell death in HT-22 is characterized as necroptosis. Moreover, increasing evidence suggests that glutamate treated HT22 cells lack caspase activation and glutamate induced cell death proceeds independently of the bcl-2 family proteins so in this cell line glutamate induced apoptosis is mediated via the caspase independent pathway which involves calpain and AIF and is accompanied by DNA ladder formation but not chromatin condensation. AIF translocation from mitochondria to the nucleus has been identified as the final step of caspase independent mitochondrial death signaling in neurons.

Human Teratocarcinoma Cell Line – Ntera /D1 (NT-2)

Ntera-2 cell line is derived from a pluripotent embryonal testicular carcinoma. Upon treatment with RA, NT2 precursors are differentiated into NT2N cells, which are identical to neurons, and the majority of them express iCluRs. NT2 cells are immunoreactive to the cholinergic markers choline acetyl-transferase, vesicular acetylcholine transporter, and the non-phosphorylated form of neurofilament H, all indicative of motor neurons. The NT2 system may thus be well-suited for research related to motor neuron diseases. Additionally NT-2N cells are able to secrete amyloid precursor protein constituting a model cell line for Alzheimer’s disease studies.

Both NMDA and non-NMDA glutamate receptor channels have been identified electrophysiologically and mRNAs for several subtypes of glutamate receptors have been detected.NT-2N cells are susceptible to both NMDA and non-NMDA mediated excitotoxicity (;; Figure 3). High concentrations of glutamate on NT-2N can also inhibit the CySS/glutamate antiporter (Xc-), diminish GSH, thus causing oxidative glutamate toxicity (;; Figure 4).

According to, these cells exhibit an excitotoxic response characterized by the absence of NOS and NADPH activity, while, support that NO is involved in the excitotoxic response of NT-2. Regularly, astrocytes are the main source of NO, however, it has been shown that NT2 neurons can produce NO and therefore increase levels of cGMP. In this cell line hypoxia is studied in relation to excitotoxicity and it has been shown that NMDA antagonist (MK801) can offer protection against cell death thus directly connecting hypoxia and excitotoxicity NT2 cells are mainly used to study the neuroprotective potential of glutamate antagonists.

Cell death in NT-2 cell does not seem to be effected by means of caspase 3 activation alone, since addition of the NMDA antagonist MK801 results in synergistic protection (; Table 2).

Oligodendroglial Lineage Cells

Oligodendroglial lineage cells are derived from CG-4-immortalized rat O-2A progenitor cells and are established as an in vitro model for oligodendroglial cell studies. Failure of MK-801, to attenuate kainate-induced cell damage under excitotoxic conditions has led to the conclusion that OLCs do not express NMDARs and that excitotoxicity in oligodendrocytes is mediated through non-NMDA glutamatergic receptors. In vitro evidence support that although both CG-4 and non-immortalized rat OLCs transcribe the NMDA GluR subunit genes NMDAR1 and NMDAR2D they do not translate NMDAR1 GluR protein.

Excitotoxic stimuli can damage oligodendroglial cells by means of Ca2+ entry which leads to Ca2+ dyshomeostasis and mitochondrial membrane alterations. These changes can lead to release of cytochrome c and AIF exhibiting a proapoptotic action. Death of oligodentroglial cells can be either caspase-depended or caspase- independent. The molecular events observed after glutamate excitotoxicity are shown in Figure 3. Excitotoxic stimuli results in increased production of ROS, depolarization of the mitochondrial membrane and release of caspase-activating proapoptotic factors. Whether cell demise is mediated via necrosis or apoptosis, it is determined through the relative contribution of the above events. Consequently, cells die via apoptosis or necrosis, as is observed in excitotoxic models. Overexpression of Bcl2 and Bcl-xl can prevent cell death in cases of mild excitotoxic insults, whereas other members of this family such as Bad or Bax have a proapoptotic role and are involved in excitotoxicity induced mitochondrial dysfunction (; Table 2).

C6 Cell Line

Although it has been shown that C6 rat glioma cells express iGluRs, it seems that excitotoxicity in this cell line is mediated by mGluRs. Concurrently studied C6 and PRCNs cells, showed that in PCRNs cells mGluRs levels are down regulated and the death rate is increased, after treatment with glutamate, compared to C6 cells which were resistant to excitotoxicity, and after 24/48 h the levels of mGluRs were increased. GSH depletion seems to be responsible for the development of oxidative stress in C6 cells (;; Figure 4).

showed, that oxidized extracellular Cys/CySS (CySS) redox state in C6 glial cells, induced a significant increase in mGluR5-mediated phosphorylation of ERK kinases. Cys/CySS redox could be blocked by U0126 an inhibitor of MEK/MAPK and a specific mGluR5 antagonist, 2-methyl-6-(phenylethynyl) pyridine (MPEP). Activation of mGluR5 by oxidized extracellular Cys/CySS affected the expression of NF-κB and inducible iNOS.

Moreover A1-mediated adenylyl cyclase inhibition and A2A-mediated adenylyl cyclase stimulation were, respectively, increased and decreased after glutamate exposure.

Neuroprotective responses activated due to loss of neural network and cell death were, the increased expression of the stress protein HSP70, chaperone GRP78, and of BDNF.

Primary Rat Astrocytes

Primary rat astrocytes are widely used to investigate the protective effect of glial cells against excitotoxic neuronal trauma, specifically via astrocytic glutamate transporters GLT-1 (EAAT2) and GLAST (EAAT1), which are the main glutamate transporters in the CNS, taking up most of excess glutamate from the synaptic cleft to prevent excitotoxic neuronal death. Although astrocytes appear to be capable of expressing all five of the known EAAT isoforms (i.e., termed EAATs 1–5) in humans, the rodent glutamate aspartate transporter GLAST; ortholog of human EAAT1, and the glutamate transporter 1 GLT-1; ortholog of human EAAT2, are thought to be the predominantly expressed glutamate transporters in rodent astrocytes in their effort to prove that raloxifene (RX) upregulates glutamate transporters in rat primary astrocytes, found that this happens through the activation of multiple signaling pathways including ERK, EGFR, and CREB mediated by estrogen receptors (ERs) ER-a, ER-b, and GPR30. At the transcriptional level, NF-κB played a critical role in RX-induced GLT-1 expression, while TNF-a reduced GLT-1 promoter activity, mRNA and protein levels in primary astrocytes.

Ionotropic glutamate receptor or mGluRs are known to be expressed in cultured astrocytes. Although kainate receptor activation was not directly assessed, clear evidence for a functional expression of these iGluRs in astrocytes is lacking. Groups II and III mGluRs do not appear to be expressed by rodent astrocytes under standard culture conditions.

Furthermore, potassium channels Kir4.1 abundantly expressed in astrocytes contribute to K+ spatial buffering, a fundamental mechanism in maintaining neuronal excitability and synaptic transmission and are implicated in the regulation of cell volume. Down regulation of Kir4.1 channels expression has been reported to decrease glutamate (Glu) uptake in cultured astrocytes. have shown that over-activation of astroglial NMDA receptors, is a primary cause of the reduction of Kir4.1 expression in CNS disorders associated with increased exposure to Glu, giving a new insight to the excitotoxic contribution of NMDARs.

Primary Cortical Rat Neurons

Despite of all the disadvantages pertaining to their culture, PRCNs are widely used for excitotoxicity experiments, because they present all the characteristics of living neurons activated by iGluRs agonists. Additionally the activation of NMDARs was verified after incubation with NMDA.

in an effort to prove the anti-inflammatory effect of Vitis amurensis found out that excitotoxicity was induced not only by NMDARs but also due to the depletion of GSH levels and lipid peroxidation. MAPKs, cyclooxygenase-2 (COX-2), and pro-apoptotic proteins were also found to be active in these neurons.

supported the involvement of MAPK pathways in NMDAR-induced apoptosis of rat cortical neurons. Current studies show that treatment of cortical neurons with glutamate resulted in an increase in Bax with a decrease in Bcl-2 proteins, loss of the MMP followed by a release of cytochrome c, and activation of caspase-9, representing the classical mitochondrial apoptotic pathway (Figure 3).

Concerning neuroprotection, adenosine A2A receptor subtype stimulation induced the activation of Akt-GSK-3b signaling pathway. The blockade of this signaling pathway with specific inhibitors abolished the increase of BDNF production, possibly via modulation of ERK1/2- CREB pathway. The physiological roles of A2A receptor-induced BDNF production was demonstrated by the protection of neurons from the excitotoxicity and increased neurite extension, as well as synapse formation from immature and mature neurons. Taken together, activation of A2A receptor regulates BDNF production in rat cortical neurons, which provides a neuroprotective action (; Table 1).

RGC-5 (Retinal Ganglion Cells)

Retinal ganglion cell (RGC-5) line is used widely in glaucoma research. This cell line simulates retinal ganglion cells as it is designated positive for certain characteristics of retinal ganglia, including Thy-1 and Brn-3C expression, and for sensitivity to glutamate excitotoxicity upon neurotrophin withdrawal. RGC-5 cell line has been widely used to study the Xc- antiporter because retina is extremely vulnerable to oxidative stress (Figure 4). It must be noted that there is controversy concerning the origin of the RGC-5 cell line. have shown utilizing mitochondrial and nuclear DNA analysis that the cell line is of mouse origin (Mus musculus) and not of rat origin as originally was thought. Furthermore, recent evidence has surfaced from which point out that the RGC-5 cell line may have been mischaracterized and actually be is cell line 661W, a mouse SV-40 T antigen transformed photoreceptor cell line. Thus, caution is advised in drawing conclusions from data extrapolated from experiments using RGC-5 cell line as well as using the aforementioned cell line as a retinal ganglion cell line.

Retinal ganglion cells express σ1-receptor, which is believed to induce neuroprotection against excitotoxicity. Hayashi and Su have shown that σ1 receptors are localized both in the ER and on the plasma membrane in many organs including the eye. The receptor is mainly localized in ER, with two transmembrane regions that have the ability to translocate to the plasma membrane upon agonist stimulation or under stressful conditions. This translocation probably gives σ1 receptor the ability to reach plasma membrane and regulate membrane channels including voltage-gated and ligand-gated Ca2+, K+, Na+, Cl-, and SK ion channels. In vitro exposure of cultured rat brain neurons to selective σ-receptor ligands protects cells against glutamate or NMDA exposure. Both excitotoxicity and oxidative glutamate toxicity have been proposed as possible mechanisms of RGC injury and cell death.

Moreover, in vitro glutamate treatment increased BDNF mRNA and protein expression and also caused a release of BDNF in the culture media. NF-κB activation was observed in response to glutamate treatment and it is postulated that increased BDNF expression is stimulated through NF-κB activation. Also CaMKII inhibitor, AIP, may play a neuroprotective role by enhancing the release of BDNF in glutamate treated RGC-5 cells. The BDNF/TrkB signaling pathway plays a pivotal role in RGC survival. Decline in the BDNF/TrkB signaling is an important observation in the RGCs in glaucoma disease. Over activation of glutamate receptors and the resulting Ca2+ overload stimulates calpains which target cytoskeletal proteins, kinases and phosphatases, membrane receptors and transporters (; Figure 3). Concerning the TrkB receptors, it is well-established that the trkB gene encodes a full length receptor tyrosine kinase (TrkB.FL; ). Under excitotoxic conditions calpain mediates TrkB.FL cleavage results in up regulation of the truncated TrkB isoform (TrkB.T). This is pivotal for cell survival since it results in the inactivation of RhoA-GTPase and downstream inhibition of pro-death pathways of p38/MAPK and JNK/c-Jun signaling. BDNF stimulation of TrkB receptors results in the activation of intracellular signaling pathways of Akt and the MAPKs extracellular signal-regulated kinases 1 and 2 (ERK 1/2), thus promoting cell survival.

SCN2.2 Cell Line

The hypothalamic SCN is a brain region that controls circadian rhythms and is endogenously resistant to excitotoxicity in vivo. This in vivo resistance was first established in the 1980s. In vitro studies of the ability of these cells to resist the toxic effects of glutamate would probably be the first step for excitotoxicity treatment.

It has been demonstrated that SCN2.2 (immortalized SCN cell line derived from rat SCN) retains resistance to glutamate toxicity under conditions that are toxic to other immortalized cell lines. This ability may provide insights into signaling pathways that offer endogenous neuroprotection in SCN. SCN2.2 cells retain the ability to respond to glutamate since in vitro studies have proved the presence of functional NMDAR subunits NR2A, NR2B, and NR2D. This fact enforces the perception that lack of excitotoxicity in SCN2.2 is not because of incapability to respond to the glutamate stimuli., supported that excitotoxic resistance in SCN2.2 is an endogenous ability and is not due to glutamate uptake by glia. In addition, experimental evidence support that SCN2.2 have higher levels of AkT activity than other cell lines. Activation of Akt pathway (PKB/Akt/PI3) is correlated with neuroprotection since Akt pathway stimulates the expression of many neuroprotective factors such as: estrogens, brain-derived neurotrophic factor, insulin-like growth factor and tumor necrosis growth factor.

In vitro, SCN2.2 excitotoxic resistance was evaluated in comparison with GT1-7 (a hypothalamic cell line derived from embryonic GnRH) which served as a neuronal control and has been widely used in neurotoxicity studies. Glutamate treated SCN2.2 and GT1-7 (10 mmol/L) resulted in activation of different signaling pathways. SCN2.2 exposure to glutamate resulted in activation of the anti-apoptotic ERK/MAPK pathway without affecting the pro-apoptotic p38/MAPK pathway, whereas in GT1-7 was noted an increase in p38/MAPK pathway and decrease in ERK/MAPK pathway (; Table 1).

Moreover in GT1-7 cells glutamate treatment resulted in increased levels of caspase-3 and BID protein, with subsequent DNA damage and cell death, while in SCN2.2 glutamate didn’t affect caspase-3 activity. Increased caspase 3 activity and cell death in SCN2.2 was noticed only after pretreatment with PD98059 (inhibitor of ERK/MAPK) which resulted in NMDAR-mediated death via an apoptotic pathway.These results support the connection between activation of ERK/MAPK pathway and cell survival. More specifically, activation of ERK/MAPK pathway stimulates the release of molecules such as (a) CREB and (b) mammalian target of rapamycin. The activation of the above intracellular molecules through ERK/MAPK pathway plays a key role to cell survival. It is worth mentioning that treatment with BDNF also up regulates ERK/MAPK pathway.

Conclusion

From the information presented above becomes evident that excitotoxicity is a multifactorial and complex phenomenon. Depending on the extracellular glutamate concentration (below 20 μM) the glutamate receptors alone come into play increasing the intracellular Ca2+ concentration. In higher extracellular glutamate concentrations, besides the action of glutamate receptors, the antiporter XC- exchanges intracellular CySS for glutamate, thus eventually depleting the cells of their GSH reducing potential. In addition in certain conditions the reverse action of glutamate transporters (EAATs) contribute to increased extracellular glutamate concentration.

Different cell lines differ in their responses when exposed to glutamate. In some cell lines glutamate toxicity is exerted through over activation of NMDA, AMPA, or kainate receptors whereas in other cell lines lacking such receptors, the toxicity is due to glutamate induced oxidative stress (Table 2). Another point worth mentioning is the differentiation of temporal characteristics of the signaling cascades in different cell lines, such as time and extent of activation, that play a pivotal role in promoting either cell survival or cell death. Different researchers used different exposure times and varying concentrations of glutamate to study excitotoxicity in their cell model systems.

The evolving understanding of cell death mechanisms also contributed in part to the hazy picture of excitotoxic cell death. Today, we understand many types of cell death, necrosis and programmed cell death. Programmed cell death can be caspase dependent (apoptosis), caspase independent calpain dependent (necroptosis or apoptosis like programmed cell death) and caspase independent cathepsin dependent (autophagic cell death; ). The study of excitotoxicity should take into consideration these facts. We recognized the need of a well-defined system that can distinguish excitotoxicity from oxidative glutamate toxicity and take into account our current view of necrosis or programmed cell death in order to decipher the response of the nerve cell to increased extracellular glutamate concentration.

The response of the cells under such conditions can be addressed by a concerted proteomics approach in order to assess the end result of the activation of the multiple intracellular signaling cascades initiated by the excitotoxic insult. It is also of great interest to examine the kinetics of the key pathways involved in order to assess their implication in cell survival or cell death under the stimulus of glutamate toxicity.

Herein are collected and presented the cell models, used to study excitotoxicity and the findings reported so far with respect to the defense and cell death mechanisms, elicited by elevated extracellular glutamate concentration.

Author Contributions

AK contributed to the conception of the theme-axis of this review and to the interpretation of the collected information. ES contributed to the conception of the work and also to analysis and interpretation of the information TV contributed also to the acquisition and analysis. KP contributed to the collection and analysis of the data. All the aforementioned authors cooperated for the drafting of the review, its final approval, and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References 227

  1. 1.

    Ahern G. P. Klyachko V. A. Jackson M. B. (2002 ). cGMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO. Trends Neurosci. 25 510–517

    Not in our library10.1016/s0166-2236(02)02254-3

  2. 2.

    Akundi R. S. Hüll M. Clement H. W. Fiebich B. L. (2003 ). 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) induces apoptosis in human neuroblastoma cell lines. Ann. N. Y. Acad. Sci. 1010 304–306

    Not in our library10.1196/annals.1299.053

  3. 3.

    Albasanz J. L. Ros M. Martin M. (1997 ). Characterization of metabotropic glutamate receptors in rat C6 glioma cells. Eur. J. Pharmacol. 326 85–91

    Not in our library10.1016/s0014-2999(97)00154-4

  4. 4.

    Alberdi E. Sánchez-Gómez M. V. Marino A. Matute C. (2002 ). Ca(2+) influx through AMPA or kainate receptors alone is sufficient to initiate excitotoxicity in cultured oligodendrocytes. Neurobiol. Dis. 9 234–243

    Not in our library10.1006/nbdi.2001.0457

  5. 5.

    Ali D. W. Salter M. W. (2001 ). NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity. Curr. Opin. Neurobiol. 11 336–342

    Not in our library10.1016/s0959-4388(00)00216-6

  6. 6.

    Allen J. W. Ivanova S. A. Fan L. Espey M. G. Basile A. S. Faden A. I. (1999 ). Group II metabotropic glutamate receptor activation attenuates traumatic neuronal injury and improves neurological recovery after traumatic brain injury. J. Pharmacol. Exp. Ther. 290 112–120.

    Not in our library

  7. 7.

    Almasieh M. Wilson A. M. Morquette B. Cueva Vargas J. L. Di P. A. (2012 ). The molecular basis of retinal ganglion cell death in glaucoma. Prog. Retin. Eye Res. 31 152–181

    Not in our library10.1016/j.preteyeres.2011.11.002

  8. 8.

    Ambrosini A. Bresciani L. Fracchia S. Brunello N. Racagni G. (1995 ). Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit N-methyl-D-aspartate receptor activity and prevent neurotoxicity in mesencephalic neurons in vitro. Mol. Pharmacol. 47 1057–1064.

    Not in our library

  9. 9.

    Anderson C. M. Swanson R. A. (2000 ). Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 32 1–14

    Not in our library10.1002/1098-1136(200010)32:1<1::aid-glia10>3.0.co;2-w

  10. 10.

    Ankarcrona M. Dypbukt J. M. Bonfoco E. Zhivotovsky B. Orrenius S. Lipton S. A. (1995 ). Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15 961–973

    Not in our library10.1016/0896-6273(95)90186-8

  11. 11.

    Anrather J. Racchumi G. Iadecola C. (2006 ). NF-kappaB regulates phagocytic NADPH oxidase by inducing the expression of gp91phox. J. Biol. Chem. 281 5657–5667

    Not in our library10.1074/jbc.m506172200

  12. 12.

    Antonelli T. Ferraro L. Fuxe K. Finetti S. Fournier J. Tanganelli S. (2004 ). Neurotensin enhances endogenous extracellular glutamate levels in primary cultures of rat cortical neurons: involvement of neurotensin receptor in NMDA induced excitotoxicity. Cereb. cortex 14 466–473

    Not in our library10.1093/cercor/bhh008

  13. 13.

    Aoun P. Simpkins J. W. Agarwal N. (2003 ). Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 44 2999–3004

    Not in our library10.1167/iovs.02-1060

  14. 14.

    Attwell D. (2000 ). Brain uptake of glutamate: food for thought. J. Nutr. 130 1023S–1025S.

    Not in our library10.1093/jn/130.4.1023s

  15. 15.

    Bal-Price A. Brown G. C. (2000 ). Nitric-oxide-induced necrosis and apoptosis in PC12 cells mediated by mitochondria. J. Neurochem. 75 1455–1464

    Not in our library10.1046/j.1471-4159.2000.0751455.x

  16. 16.

    Beske P. H. Jackson D. A. (2012 ). NADPH oxidase mediates the oxygen-glucose deprivation/reperfusion-induced increase in the tyrosine phosphorylation of the N-methyl-D-aspartate receptor NR2A subunit in retinoic acid differentiated SH-SY5Y Cells. J. Mol. Signal. 7:15

    Not in our library10.1186/1750-2187-7-15

  17. 17.

    Bloom F. E. (1994 ). Neuroscience: From the Molecular to the Cognitive. Amsterdam: Elsevier.

    Not in our library

  18. 18.

    Bonfoco E. Krainc D. Ankarcrona M. Nicotera P. Lipton S. A. (1995 ). Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. U.S.A. 92 7162–7166

    Not in our library10.1073/pnas.92.16.7162

  19. 19.

    Bonfoco E. Zhivotovsky B. Rossi A. D. Aguilar-Santelises M. Orrenius S. Lipton S. A. (1996 ). BCL-2 delay apoptosis and PARP cleavage induced by NO donors in GT1-7 cells. Neuroreport 8 273–276

    Not in our library10.1097/00001756-199612200-00054

  20. 20.

    Bottum K. Poon E. Haley B. Karmarkar S. Tischkau S. A. (2010 ). Suprachiasmatic nucleus neurons display endogenous resistance to excitotoxicity. Exp. Biol. Med. (Maywood) 235 237–246

    Not in our library10.1258/ebm.2009.009244

  21. 21.

    Bourque M. Dluzen D. E. Di P. T. (2009 ). Neuroprotective actions of sex steroids in Parkinson’s disease. Front. Neuroendocrinol. 30:142–157

    Not in our library10.1016/j.yfrne.2009.04.014

  22. 22.

    Boyce M. Yuan J. (2006 ). Cellular response to endoplasmic reticulum stress: a matter of life or death. Cell Death Differ. 13 363–373

    Not in our library10.1038/sj.cdd.4401817

  23. 23.

    Bridges R. J. Natale N. R. Patel S. A. (2012 ). System xc(-) cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. Br. J. Pharmacol. 165 20–34

    Not in our library10.1111/j.1476-5381.2011.01480.x

  24. 24.

    Brown G. C. (2010 ). Nitric oxide and neuronal death. Nitric Oxide 23 153–165

    Not in our library10.1016/j.niox.2010.06.001

  25. 25.

    Byrnes K. R. Loane D. J. Faden A. I. (2009 ). Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders. Neurotherapeutics 6 94–107

    Not in our library10.1016/j.nurt.2008.10.038

  26. 26.

    Cao R. Lee B. Cho H. Y. Saklayen S. Obrietan K. (2008 ). Photic regulation of the mTOR signaling pathway in the suprachiasmatic circadian clock. Mol. Cell. Neurosci. 38 312–324

    Not in our library10.1016/j.mcn.2008.03.005

  27. 27.

    Casado M. Lopez-Guajardo A. Mellstrom B. Naranjo J. R. Lerma J. (1996 ). Functional N-methyl-D-aspartate receptors in clonal rat phaeochromocytoma cells. J. Physiol. 490 391–404

    Not in our library10.1113/jphysiol.1996.sp021153

  28. 28.

    Castillo C. A. Leon D. A. Ballesteros-Yanez I. Iglesias I. Martin M. Albasanz J. L. (2010a ). Glutamate differently modulates metabotropic glutamate receptors in neuronal and glial cells. Neurochem. Res. 35 1050–1063

    Not in our library10.1007/s11064-010-0154-y

  29. 29.

    Castillo C. A. León D. A. Ballesteros-Yáñez I. Albasanz J. L. Martín M. (2010b ). Glutamate differently modulates excitatory and inhibitory adenosine receptors in neuronal and glial cells. Neurochem. Int. 57 33–42

    Not in our library10.1016/j.neuint.2010.04.008

  30. 30.

    Cernaianu G. Brandmaier P. Scholz G. Ackermann O. P. Alt R. Rothe K. (2008 ). All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit. J. pediatr. Surg. 43 1284–1294

    Not in our library10.1016/j.jpedsurg.2008.01.007

  31. 31.

    Chen J. Chua K. W. Chua C. C. Yu H. Pei A. Chua B. H. (2011 ). Antioxidant activity of 78-dihydroxyflavone provides neuroprotection against glutamate-induced toxicity. Neurosci. Lett. 499 181–185

    Not in our library10.1016/j.neulet.2011.05.054

  32. 32.

    Chen M. J. Ng J. M. Peng Z. F. Manikandan J. Yap Y. W. Llanos R. M. (2013 ). Gene profiling identifies commonalities in neuronal pathways in excitotoxicity: evidence favouring cell cycle re-activation in concert with oxidative stress. Neurochem. Int. 62 719–730

    Not in our library10.1016/j.neuint.2012.12.015

  33. 33.

    Cheng B. Martinez A. A. Morado J. Scofield V. Roberts J. L. Maffi S. K. (2012 ). Retinoic acid protects against proteasome inhibition associated cell death in SH-SY5Y cells via the AKT pathway. Neurochem. Int. 62 31–42

    Not in our library10.1016/j.neuint.2012.10.014

  34. 34.

    Cheng J. Standifer K. M. Tublin P. R. Su W. Pasternak G. W. (1995 ). Demonstration of kappa 3-opioid receptors in the SH-SY5Y human neuroblastoma cell line. J. Neurochem. 65 170–175

    Not in our library10.1046/j.1471-4159.1995.65010170.x

  35. 35.

    Cheng L. Sapieha P. Kittlerova P. Hauswirth W. W. Di P. A. (2002 ). TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo. J. Neurosci. 22 3977–3986.

    Not in our library10.1523/jneurosci.22-10-03977.2002

  36. 36.

    Conn P. J. Pin J. P. (1997 ). Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37 205–237

    Not in our library10.1146/annurev.pharmtox.37.1.205

  37. 37.

    Culmsee C. Zhu C. Landshamer S. Becattini B. Wagner E. Pellecchia M. (2005 ). Apoptosis-inducing factor triggered by poly(ADP-ribose) polymerase and bid mediates neuronal cell death after oxygen-glucose deprivation and focal cerebral ischemia. J. Neurosci. 25 10262–10272

    Not in our library10.1523/jneurosci.2818-05.2005

  38. 38.

    Dahlmann-Noor A. H. Vijay S. Limb G. A. Khaw P. T. (2010 ). Strategies for optic nerve rescue and regeneration in glaucoma and other optic neuropathies. Drug Discov. Today 15 287–299

    Not in our library10.1016/j.drudis.2010.02.007

  39. 39.

    Daikhin Y. Yudkoff M. (2000 ). Compartmentation of brain glutamate metabolism in neurons and glia. J. Nutr. 130 1026S–1031S.

    Not in our library10.1093/jn/130.4.1026s

  40. 40.

    Danbolt N. C. (2001 ). Glutamate uptake. Prog. Neurobiol. 65 1–105

    Not in our library10.1016/s0301-0082(00)00067-8

  41. 41.

    Davis J. B. Maher P. (1994 ). Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line. Brain Res. 652 169–173

    Not in our library10.1016/0006-8993(94)90334-4

  42. 42.

    De P. C. Falcone S. Panzeri C. Radice S. Bassi M. T. Clementi E. (2008 ). Endothelial nitric oxide synthase overexpression by neuronal cells in neurodegeneration: a link between inflammation and neuroprotection. J. Neurochem. 106 193–204

    Not in our library10.1111/j.1471-4159.2008.05351.x

  43. 43.

    Denninger J. W. Marletta M. A. (1999 ). Guanylate cyclase and the.NO/cGMP signaling pathway. Biochim. Biophys. Acta 1411 334–350

    Not in our library10.1016/s0005-2728(99)00024-9

  44. 44.

    Di X. Yan J. Zhao Y. Zhang J. Shi Z. Chang Y. (2010 ). L-theanine protects the APP (Swedish mutation) transgenic SH-SY5Y cell against glutamate-induced excitotoxicity via inhibition of the NMDA receptor pathway. Neuroscience 168 778–786

    Not in our library10.1016/j.neuroscience.2010.04.019

  45. 45.

    Dikic I. Tokiwa G. Lev S. Courtneidge S. A. Schlessinger J. (1996 ). A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 383 547–550

    Not in our library10.1038/383547a0

  46. 46.

    Doshi S. Lynch D. R. (2009 ). Calpain and the glutamatergic synapse. Front. Biosci. (Schol. Ed.) 1:466–476.

    Not in our library10.2741/s38

  47. 47.

    Du P. Hu S. Cheng Y. Li F. Li M. Li J. (2012 ). Photodynamic therapy leads to death of C6 glioma cells partly through AMPAR. Brain Res. 1433 153–159

    Not in our library10.1016/j.brainres.2011.11.048

  48. 48.

    Ebling F. J. (1996 ). The role of glutamate in the photic regulation of the suprachiasmatic nucleus. Prog. Neurobiol. 50 109–132

    Not in our library10.1016/s0301-0082(96)00032-9

  49. 49.

    Edwards M. A. Loxley R. A. Williams A. J. Connor M. Phillips J. K. (2007 ). Lack of functional expression of NMDA receptors in PC12 cells. Neurotoxicology 28 876–885

    Not in our library10.1016/j.neuro.2007.04.006

  50. 50.

    Faden A. I. Ivanova S. A. Yakovlev A. G. Mukhin A. G. (1997 ). Neuroprotective effects of group III mGluR in traumatic neuronal injury. J. Neurotrauma 14 885–895

    Not in our library10.1089/neu.1997.14.885

  51. 51.

    Fallarini S. Miglio G. Paoletti T. Minassi A. Amoruso A. Bardelli C. (2009 ). Clovamide and rosmarinic acid induce neuroprotective effects in in vitro models of neuronal death. Br. J. Pharmacol. 157 1072–1084

    Not in our library10.1111/j.1476-5381.2009.00213.x

  52. 52.

    Fan W. Agarwal N. Cooper N. G. (2006 ). The role of CaMKII in BDNF-mediated neuroprotection of retinal ganglion cells (RGC-5). Brain Res. 1067 48–57

    Not in our library10.1016/j.brainres.2005.10.030

  53. 53.

    Fang J. Han D. Hong J. Tan Q. Tian Y. (2012 ). The chemokine, macrophage inflammatory protein-2gamma, reduces the expression of glutamate transporter-1 on astrocytes and increases neuronal sensitivity to glutamate excitotoxicity. J. Neuroinflammation 9:267

    Not in our library10.1186/1742-2094-9-267

  54. 54.

    Finkbeiner S. Greenberg M. E. (1996 ). Ca(2+)-dependent routes to ras: mechanisms for neuronal survival, differentiation, and plasticity? Neuron 16 233–236

    Not in our library10.1016/s0896-6273(00)80040-9

  55. 55.

    Foran E. Rosenblum L. Bogush A. Pasinelli P. Trotti D. (2014 ). Sumoylation of the astroglial glutamate transporter EAAT2 governs its intracellular compartmentalization. Glia 62 1241–1253

    Not in our library10.1002/glia.22677

  56. 56.

    Fukui M. Song J. H. Choi J. Choi H. J. Zhu B. T. (2009 ). Mechanism of glutamate-induced neurotoxicity in HT22 mouse hippocampal cells. Eur. J. Pharmacol. 617 1–11

    Not in our library10.1016/j.ejphar.2009.06.059

  57. 57.

    Gliyazova N. S. Huh E. Y. Ibeanu G. C. (2013 ). A novel phenoxy thiophene sulphonamide molecule protects against glutamate evoked oxidative injury in a neuronal cell model. BMC Neurosci. 14:93

    Not in our library10.1186/1471-2202-14-93

  58. 58.

    Greene L. A. Tischler A. S. (1976 ). Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. U.S.A. 73 2424–2428

    Not in our library10.1073/pnas.73.7.2424

  59. 59.

    Grohm J. Plesnila N. Culmsee C. (2010 ). Bid mediates fission, membrane permeabilization and peri-nuclear accumulation of mitochondria as a prerequisite for oxidative neuronal cell death. Brain Behav. Immun. 24 831–838

    Not in our library10.1016/j.bbi.2009.11.015

  60. 60.

    Gupta V. K. You Y. Li J. C. Klistorner A. Graham S. L. (2013 ). Protective effects of 7,8-dihydroxyflavone on retinal ganglion and RGC-5 cells against excitotoxic and oxidative stress. J. Mol. Neurosci. 49 96–104

    Not in our library10.1007/s12031-012-9899-x

  61. 61.

    Gursoy E. Cardounel A. Kalimi M. (2001 ). Pregnenolone protects mouse hippocampal (HT-22) cells against glutamate and amyloid beta protein toxicity. Neurochem. Res. 26 15–21

    Not in our library10.1023/a:1007668213330

  62. 62.

    Han B. H. Holtzman D. M. (2000 ). BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J. Neurosci. 20 5775–5781.

    Not in our library10.1523/jneurosci.20-15-05775.2000

  63. 63.

    Han D. Sen C. K. Roy S. Kobayashi M. S. Tritschler H. J. Packer L. (1997 ). Protection against glutamate-induced cytotoxicity in C6 glial cells by thiol antioxidants. Am. J. Physiol. 273 R1771–R1778.

    Not in our library10.1152/ajpregu.1997.273.5.r1771

  64. 64.

    Hanko E. Hansen T. W. Almaas R. Paulsen R. Rootwelt T. (2006 ). Synergistic protection of a general caspase inhibitor and MK-801 in bilirubin-induced cell death in human NT2-N neurons. Pediatr. Res. 59 72–77

    Not in our library10.1203/01.pdr.0000191135.63586.08

  65. 65.

    Hara M. R. Agrawal N. Kim S. F. Cascio M. B. Fujimuro M. Ozeki Y. (2005 ). S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat. Cell Biol. 7 665–674

    Not in our library10.1038/ncb1268

  66. 66.

    Hay N. Sonenberg N. (2004 ). Upstream and downstream of mTOR. Genes Dev. 18 1926–1945

    Not in our library10.1101/gad.1212704

  67. 67.

    Hayashi T. Su T. P. (2003 ). Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. J. Pharmacol. Exp. Ther. 306 718–725

    Not in our library10.1124/jpet.103.051284

  68. 68.

    Hertz L. Peng L. Dienel G. A. (2007 ). Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis. J. Cereb. Blood Flow Metab. 27 219–249

    Not in our library10.1038/sj.jcbfm.9600343

  69. 69.

    Hetman M. Kanning K. Cavanaugh J. E. Xia Z. (1999 ). Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J. Biol. Chem. 274 22569–22580

    Not in our library10.1074/jbc.274.32.22569

  70. 70.

    Hetman M. Kharebava G. (2006 ). Survival signaling pathways activated by NMDA receptors. Curr. Top. Med. Chem. 6 787–799

    Not in our library10.2174/156802606777057553

  71. 71.

    Hirata Y. Furuta K. Suzuki M. Oh-hashi K. Ueno Y. Kiuchi K. (2012 ). Neuroprotective cyclopentenone prostaglandins up-regulate neurotrophic factors in C6 glioma cells. Brain Res. 1482 91–100

    Not in our library10.1016/j.brainres.2012.09.008

  72. 72.

    Holohean A. M. Hackman J. C. Davidoff R. A. (1999 ). Mechanisms involved in the metabotropic glutamate receptor-enhancement of NMDA-mediated motoneurone responses in frog spinal cord. Br. J. Pharmacol. 126 333–341

    Not in our library10.1038/sj.bjp.0702263

  73. 73.

    Hsieh Y. C. Athar M. Chaudry I. H. (2009 ). When apoptosis meets autophagy: deciding cell fate after trauma and sepsis. Trends Mol. Med. 15 129–138

    Not in our library10.1016/j.molmed.2009.01.002

  74. 74.
    Protection of SH-SY5Y Neuronal Cells from Glutamate-Induced Apoptosis by 3, 6 ′ -Disinapoyl Sucrose, a Bioactive Compound Isolated from Radix Polygala · 2012
    No notice
  75. 75.

    Ishikawa K. Nash S. R. Nishimune A. Neki A. Kaneko S. Nakanishi S. (1999 ). Competitive interaction of seven in absentia homolog-1A and Ca2+/calmodulin with the cytoplasmic tail of group 1 metabotropic glutamate receptors. Genes Cells 4 381–390

    Not in our library10.1046/j.1365-2443.1999.00269.x

  76. 76.

    Ismail N. Ismail M. Fathy S. F. Musa S. N. Imam M. U. Foo J. B. (2012 ). Neuroprotective effects of germinated brown rice against hydrogen peroxide induced cell death in human SH-SY5Y cells. Int. J. Mol. Sci. 13 9692–9708

    Not in our library10.3390/ijms13089692

  77. 77.

    Itoh T. Itoh A. Pleasure D. (2003 ). Bcl-2-related protein family gene expression during oligodendroglial differentiation. J. Neurochem. 85 1500–1512

    Not in our library10.1046/j.1471-4159.2003.01795.x

  78. 78.

    Janssens N. Lesage A. S. (2001 ). Glutamate receptor subunit expression in primary neuronal and secondary glial cultures. J. Neurochem. 77 1457–1474

    Not in our library10.1046/j.1471-4159.2001.00369.x

  79. 79.

    Jeon S. J. Rhee S. Y. Ryu J. H. Cheong J. H. Kwon K. Yang S. I. (2011 ). Activation of adenosine A2A receptor up-regulates BDNF expression in rat primary cortical neurons. Neurochem. Res. 36 2259–2269

    Not in our library10.1007/s11064-011-0550-y

  80. 80.

    Johnson J. W. Ascher P. (1990 ). Voltage-dependent block by intracellular Mg2+ of N-methyl-D-aspartate-activated channels. Biophys. J. 57 1085–1090

    Not in our library10.1016/s0006-3495(90)82626-6

  81. 81.

    Johnson-Farley N. N. Patel K. Kim D. Cowen D. S. (2007 ). Interaction of FGF-2 with IGF-1 and BDNF in stimulating Akt, ERK, and neuronal survival in hippocampal cultures. Brain Res. 1154 40–49

    Not in our library10.1016/j.brainres.2007.04.026

  82. 82.

    Karki P. Webb A. Zerguine A. Choi J. Son D. S. Lee E. (2014 ). Mechanism of raloxifene-induced upregulation of glutamate transporters in rat primary astrocytes. Glia 62 1270–1283

    Not in our library10.1002/glia.22679

  83. 83.
    ERK/MAPK is essential for endogenous neuroprotection in SCN2.2 cells. · 2011
    Not checked
  84. 84.

    Karmarkar S. W. Tischkau S. (2013 ). Influences of the circadian clock on neuronal susceptibility to excitotoxicity. Front. Physiol. 4:313

    Not in our library10.3389/fphys.2013.00313

  85. 85.

    Keinanen K. Wisden W. Sommer B. Werner P. Herb A. Verdoorn T. A. (1990 ). A family of AMPA-selective glutamate receptors. Science 249 556–560

    Not in our library10.1126/science.2166337

  86. 86.

    Kelso S. R. Nelson T. E. Leonard J. P. (1992 ). Protein kinase C-mediated enhancement of NMDA currents by metabotropic glutamate receptors in Xenopus oocytes. J. Physiol. 449 705–718

    Not in our library10.1113/jphysiol.1992.sp019110

  87. 87.

    Kim T. H. Kim J. Kim Z. Huang R. B. Wang R. S. (2012 ). Khz (fusion of Ganoderma lucidum and Polyporus umbellatus mycelia) induces apoptosis by increasing intracellular calcium levels and activating JNK and NADPH oxidase-dependent generation of reactive oxygen species. PLoS ONE 7:e46208

    Not in our library10.1371/journal.pone.0046208

  88. 88.

    Kinney G. A. Slater N. T. (1993 ). Potentiation of NMDA receptor-mediated transmission in turtle cerebellar granule cells by activation of metabotropic glutamate receptors. J. Neurophysiol. 69 585–594.

    Not in our library10.1152/jn.1993.69.2.585

  89. 89.

    Klocker N. Kermer P. Weishaupt J. H. Labes M. Ankerhold R. Bahr M. (2000 ). Brain-derived neurotrophic factor-mediated neuroprotection of adult rat retinal ganglion cells in vivo does not exclusively depend on phosphatidyl-inositol-3’-kinase/protein kinase B signaling. J. Neurosci. 20 6962–6967.

    Not in our library10.1523/jneurosci.20-18-06962.2000

  90. 90.

    Kostandy B. B. (2012 ). The role of glutamate in neuronal ischemic injury: the role of spark in fire. Neurol. Sci. 33 223–237

    Not in our library10.1007/s10072-011-0828-5

  91. 91.

    Krishnamoorthy R. R. Clark A. F. Daudt D. Vishwanatha J. K. Yorio T. (2013 ). A forensic path to RGC-5 cell line identification: lessons learned. Invest. Ophthalmol. Vis. Sci. 54 5712–5719

    Not in our library10.1167/iovs.13-12085

  92. 92.
    Proteases inhibition assessment on PC12 and NGF treated cells after oxygen and glucose deprivation reveals a distinct role for aspartyl proteases. · 2011
    Not checked
  93. 93.
    Glutamate induces mitochondrial dynamic imbalance and autophagy activation: preventive effects of selenium. · 2012
    Not checked
  94. 94.

    Kume T. Kawato Y. Osakada F. Izumi Y. Katsuki H. Nakagawa T. (2008 ). Dibutyryl cyclic AMP induces differentiation of human neuroblastoma SH-SY5Y cells into a noradrenergic phenotype. Neurosci. Lett. 443 199–203

    Not in our library10.1016/j.neulet.2008.07.079

  95. 95.

    Lai T. W. Zhang S. Wang Y. T. (2014 ). Excitotoxicity and stroke: identifying novel targets for neuroprotection. Prog. Neurobiol. 115 157–188

    Not in our library10.1016/j.pneurobio.2013.11.006

  96. 96.

    Lan J. Y. Skeberdis V. A. Jover T. Zheng X. Bennett M. V. Zukin R. S. (2001 ). Activation of metabotropic glutamate receptor 1 accelerates NMDA receptor trafficking. J. Neurosci. 21 6058–6068.

    Not in our library10.1523/jneurosci.21-16-06058.2001

  97. 97.

    Landshamer S. Hoehn M. Barth N. Duvezin-Caubet S. Schwake G. Tobaben S. (2008 ). Bid-induced release of AIF from mitochondria causes immediate neuronal cell death. Cell Death Differ. 15 1553–1563

    Not in our library10.1038/cdd.2008.78

  98. 98.

    Lane D. J. Lawen A. (2013 ). The glutamate aspartate transporter (GLAST) mediates L-glutamate-stimulated ascorbate-release via swelling-activated anion channels in cultured neonatal rodent astrocytes. Cell Biochem. Biophys. 65 107–119

    Not in our library10.1007/s12013-012-9404-8

  99. 99.

    Lea P. M. Movsesyan V. A. Faden A. I. (2005 ). Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors. Br. J. Pharmacol. 145 527–534

    Not in our library10.1038/sj.bjp.0706219

  100. 100.

    Leach M. J. Marden C. M. Miller A. A. (1986 ). Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia 27 490–497

    Not in our library10.1111/j.1528-1157.1986.tb03573.x

  101. 101.

    Leclerc C. L. Chi C. L. Awobuluyi M. Sucher N. J. (1995 ). Expression of N-methyl-D-aspartate receptor subunit mRNAs in the rat pheochromocytoma cell line PC12. Neurosci. Lett. 201 103–106

    Not in our library10.1016/0304-3940(95)12145-5

  102. 102.

    Lesage A. S. De Loore K. L. Peeters L. Leysen J. E. (1995 ). Neuroprotective sigma ligands interfere with the glutamate-activated NOS pathway in hippocampal cell culture. Synapse 20 156–164

    Not in our library10.1002/syn.890200210

  103. 103.

    Lu M. Hu L. F. Hu G. Bian J. S. (2008 ). Hydrogen sulfide protects astrocytes against H(2)O(2)-induced neural injury via enhancing glutamate uptake. Free Radic. Biol. Med. 45 1705–1713

    Not in our library10.1016/j.freeradbiomed.2008.09.014

  104. 104.

    Lu S. Lu C. Han Q. Li J. Du Z. Liao L. (2011 ). Adipose-derived mesenchymal stem cells protect PC12 cells from glutamate excitotoxicity-induced apoptosis by upregulation of XIAP through PI3-K/Akt activation. Toxicology 279 189–195

    Not in our library10.1016/j.tox.2010.10.011

  105. 105.

    Luetjens C. M. Bui N. T. Sengpiel B. Munstermann G. Poppe M. Krohn A. J. (2000 ). Delayed mitochondrial dysfunction in excitotoxic neuron death: cytochrome c release and a secondary increase in superoxide production. J. Neurosci. 20 5715–5723.

    Not in our library10.1523/jneurosci.20-15-05715.2000

  106. 106.

    Luo H. R. Hattori H. Hossain M. A. Hester L. Huang Y. Lee-Kwon W. (2003 ). Akt as a mediator of cell death. Proc. Natl. Acad. Sci. U.S.A. 100 11712–11717

    Not in our library10.1073/pnas.1634990100

  107. 107.

    Ma S. Liu H. Jiao H. Wang L. Chen L. Liang J. (2012 ). Neuroprotective effect of ginkgolide K on glutamate-induced cytotoxicity in PC 12 cells via inhibition of ROS generation and Ca2+ influx. Neurotoxicology 33 59–69

    Not in our library10.1016/j.neuro.2011.11.003

  108. 108.

    Marchetti L. Klein M. Schlett K. Pfizenmaier K. Eisel U. L. (2004 ). Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. J. Biol. Chem. 279 32869–32881

    Not in our library10.1074/jbc.m311766200

  109. 109.

    McMullan S. M. Phanavanh B. Li G. G. Barger S. W. (2012 ). Metabotropic glutamate receptors inhibit microglial glutamate release. ASN Neuro 4:e00094

    Not in our library10.1042/an20120044

  110. 110.

    Mehta A. Prabhakar M. Kumar P. Deshmukh R. Sharma P. L. (2012 ). Excitotoxicity: bridge to various triggers in neurodegenerative disorders. Eur. J. Pharmacol. 698 6–18

    Not in our library10.1016/j.ejphar.2012.10.032

  111. 111.

    Meldrum B. S. (1994 ). The role of glutamate in epilepsy and other CNS disorders. Neurology 44 S14–S23.

    Not in our library

  112. 112.

    Mellon P. L. Windle J. J. Goldsmith P. C. Padula C. A. Roberts J. L. Weiner R. I. (1990 ). Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron 5 1–10

    Not in our library10.1016/0896-6273(90)90028-e

  113. 113.

    Minakami R. Jinnai N. Sugiyama H. (1997 ). Phosphorylation and calmodulin binding of the metabotropic glutamate receptor subtype 5 (mGluR5) are antagonistic in vitro. J. Biol. Chem. 272 20291–20298

    Not in our library10.1074/jbc.272.32.20291

  114. 114.

    Mollereau C. Zajac J. M. Roumy M. (2007 ). Staurosporine differentiation of NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells induces selectivity of NPFF activity towards opioid receptors. Peptides 28 1125–1128

    Not in our library10.1016/j.peptides.2007.03.001

  115. 115.

    Monyer H. Sprengel R. Schoepfer R. Herb A. Higuchi M. Lomeli H. (1992 ). Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256 1217–1221

    Not in our library10.1126/science.256.5060.1217

  116. 116.

    Munir M. Lu L. Mcgonigle P. (1995 ). Excitotoxic cell death and delayed rescue in human neurons derived from NT2 cells. J. Neurosci. 15 7847–7860.

    Not in our library10.1523/jneurosci.15-12-07847.1995

  117. 117.

    Murphy T. H. Miyamoto M. Sastre A. Schnaar R. L. Coyle J. T. (1989 ). Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2 1547–1558

    Not in our library10.1016/0896-6273(89)90043-3

  118. 118.

    Murphy T. H. Schnaar R. L. Coyle J. T. (1990 ). Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB J. 4 1624–1633.

    Not in our library

  119. 119.

    Naarala J. Nykvist P. Tuomala M. Savolainen K. (1993 ). Excitatory amino acid-induced slow biphasic responses of free intracellular calcium in human neuroblastoma cells. FEBS Lett. 330 222–226

    Not in our library10.1016/0014-5793(93)80278-3

  120. 120.

    Naarala J. Tervo P. Loikkanen J. Savolainen K. (2002 ). Blocking of carbacholGANinduced calcium mobilization by glutamate receptor antagonists. Neurosci. Res. Commun. 30 1–6

    Not in our library10.1002/nrc.10012

  121. 121.

    Nair V. D. Niznik H. B. Mishra R. K. (1996 ). Interaction of NMDA and dopamine D2L receptors in human neuroblastoma SH-SY5Y cells. J. Neurochem. 66 2390–2393

    Not in our library10.1046/j.1471-4159.1996.66062390.x

  122. 122.

    Nakagawa D. Ohshima Y. Takusagawa M. Ikota N. Takahashi Y. Shimizu S. (2001 ). Functional modification of cytochrome c by peroxynitrite in an electron transfer reaction. Chem. Pharm. Bull. (Tokyo) 49 1547–1554

    Not in our library10.1248/cpb.49.1547

  123. 123.

    Nakanishi S. Masu M. Bessho Y. Nakajima Y. Hayashi Y. Shigemoto R. (1994 ). Molecular diversity of glutamate receptors and their physiological functions. EXS 71 71–80.

    Not in our library10.1007/978-3-0348-7330-7_8

  124. 124.

    Nampoothiri M. Reddy N. D. John J. Kumar N. Nampurath G. K. Chamallamudi M. R. (2014 ). Insulin blocks glutamate-induced neurotoxicity in differentiated SH-SY5Y neuronal cells. Behav. Neurol. 2014:674164

    Not in our library10.1155/2014/674164

  125. 125.

    Ness J. K. Scaduto R. C. Wood T. L. (2004 ). IGF-I prevents glutamate-mediated bax translocation and cytochrome C release in O4+ oligodendrocyte progenitors. Glia 46 183–194

    Not in our library10.1002/glia.10360

  126. 126.

    Nguyen T. L. Kim C. K. Cho J. H. Lee K. H. Ahn J. Y. (2010 ). Neuroprotection signaling pathway of nerve growth factor and brain-derived neurotrophic factor against staurosporine induced apoptosis in hippocampal H19-7 cells. Exp. Mol. Med. 42 583–595

    Not in our library10.3858/emm.2010.42.8.060

  127. 127.

    Nicholls D. G. Budd S. L. (1998 ). Neuronal excitotoxicity: the role of mitochondria. Biofactors 8 287–299

    Not in our library10.1002/biof.5520080317

  128. 128.

    Niciu M. J. Kelmendi B. Sanacora G. (2012 ). Overview of glutamatergic neurotransmission in the nervous system. Pharmacol. Biochem. Behav. 100 656–664

    Not in our library10.1016/j.pbb.2011.08.008

  129. 129.

    Nikoletopoulou V. Markaki M. Palikaras K. Tavernarakis N. (2013 ). Crosstalk between apoptosis, necrosis and autophagy. Biochim. Biophys. Acta 1833 3448–3459

    Not in our library10.1016/j.bbamcr.2013.06.001

  130. 130.

    Nikolova S. Lee Y. S. Lee Y. S. Kim J. A. (2005 ). Rac1-NADPH oxidase-regulated generation of reactive oxygen species mediates glutamate-induced apoptosis in SH-SY5Y human neuroblastoma cells. Free Radic. Res. 39 1295–1304

    Not in our library10.1080/10715760500176866

  131. 131.

    Nixon R. A. Mathews P. M. Cataldo A. M. (2001 ). The neuronal endosomal-lysosomal system in Alzheimer’s disease. J. Alzheimers Dis. 3 97–107.

    Not in our library10.3233/jad-2001-3114

  132. 132.

    Obara-Michlewska M. Ruszkiewicz J. Zielinska M. Verkhratsky A. Albrecht J. (2014 ). Astroglial NMDA receptors inhibit expression of K4.1 channels in glutamate-overexposed astrocytes in vitro and in the brain of rats with acute liver failure. Neurochem. Int. [Epub ahead of print].

    Not in our library10.1016/j.neuint.2014.10.006

  133. 133.

    Oka A. Belliveau M. J. Rosenberg P. A. Volpe J. J. (1993 ). Vulnerability of oligodendroglia to glutamate - pharmacology, mechanisms, and prevention. J. Neurosci. 13 1441–1453.

    Not in our library10.1523/jneurosci.13-04-01441.1993

  134. 134.

    Pahlman S. Odelstad L. Larsson E. Grotte G. Nilsson K. (1981 ). Phenotypic changes of human neuroblastoma cells in culture induced by 12-O-tetradecanoyl-phorbol-13-acetate. Int. J. cancer 28 583–589

    Not in our library10.1002/ijc.2910280509

  135. 135.

    Park K. W. Nozell S. E. Benveniste E. N. (2012 ). Protective role of STAT3 in NMDA and glutamate-induced neuronal death: negative regulatory effect of SOCS3. PLoS ONE 7:e50874

    Not in our library10.1371/journal.pone.0050874

  136. 136.

    Paquet-Durand F. Bicker G. (2004 ). Hypoxic/ischaemic cell damage in cultured human NT-2 neurons. Brain Res. 1011 33–47

    Not in our library10.1016/j.brainres.2004.02.060

  137. 137.

    Paquet-Durand F. Gierse A. Bicker G. (2006 ). Diltiazem protects human NT-2 neurons against excitotoxic damage in a model of simulated ischemia. Brain Res. 1124 45–54

    Not in our library10.1016/j.brainres.2006.09.077

  138. 138.

    Penugonda S. Mare S. Lutz P. Banks W. A. Ercal N. (2006 ). Potentiation of lead-induced cell death in PC12 cells by glutamate: protection by N-acetylcysteine amide (NACA), a novel thiol antioxidant. Toxicol. Appl. Pharmacol. 216 197–205

    Not in our library10.1016/j.taap.2006.05.002

  139. 139.

    Pereira C. M. Oliveira C. R. (1997 ). Glutamate toxicity on a PC12 cell line involves glutathione (GSH) depletion and oxidative stress. Free Radic. Biol. Med. 23 637–647

    Not in our library10.1016/s0891-5849(97)00020-8

  140. 140.

    Pereira C. F. Oliveira C. R. (2000 ). Oxidative glutamate toxicity involves mitochondrial dysfunction and perturbation of intracellular Ca2+ homeostasis. Neurosci. Res. 37 227–236

    Not in our library10.1016/s0168-0102(00)00124-3

  141. 141.

    Perovic S. Pialoglou P. Schroder H. C. Pergande G. Muller W. E. (1996 ). Flupirtine increases the levels of glutathione and Bc1-2 in hNT (human Ntera/D1) neurons: mode of action of the drug-mediated anti-apoptotic effect. Eur. J. Pharmacol. 317 157–164

    Not in our library10.1016/s0014-2999(96)00712-1

  142. 142.

    Persons D. L. Yazlovitskaya E. M. Cui W. Pelling J. C. (1999 ). Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. Clin. Cancer Res. 5 1007–1014.

    Not in our library

  143. 143.

    Peterson C. Neal J. H. Cotman C. W. (1989 ). Development of N-methyl-D-aspartate excitotoxicity in cultured hippocampal neurons. Brain Res. Dev. Brain Res. 48 187–195

    Not in our library10.1016/0165-3806(89)90075-8

  144. 144.

    Peterson G. M. Moore R. Y. (1980 ). Selective effects of kainic acid on diencephalic neurons. Brain Res. 202 165–182

    Not in our library10.1016/s0006-8993(80)80042-4

  145. 145.

    Piers T. M. Kim D. H. Kim B. C. Regan P. Whitcomb D. J. Cho K. (2012 ). Translational concepts of mGluR5 in synaptic diseases of the brain. Front. Pharmacol. 3:199

    Not in our library10.3389/fphar.2012.00199

  146. 146.

    Pivovarova N. B. Nguyen H. V. Winters C. A. Brantner C. A. Smith C. L. Andrews S. B. (2004 ). Excitotoxic calcium overload in a subpopulation of mitochondria triggers delayed death in hippocampal neurons. J. Neurosci. 24 5611–5622

    Not in our library10.1523/jneurosci.0531-04.2004

  147. 147.

    Podrygajlo G. Tegenge M. A. Gierse A. Paquet-Durand F. Tan S. Bicker G. (2009 ). Cellular phenotypes of human model neurons (NT2) after differentiation in aggregate culture. Cell Tissue Res. 336 439–452

    Not in our library10.1007/s00441-009-0783-0

  148. 148.
    Neuroprotective Actions of Methylene Blue and Its Derivatives · 2012
    No notice
  149. 149.

    Pourzitaki C. Kanellos G. Klagas I. Kritis A. (2008 ). Combined treatment of aspartyl protease inhibitor and Nmda antagonist in Pc12 cells after glutamate excitotoxicity. Rev. Clin. Pharmacol. Pharmacokinet. Int. Ed. 22304–307.

    Not in our library

  150. 150.

    Pourzitaki C. Klagas I. Kaidoglou A. Tzimagiorgis G. Kritis A. (2007 ). Caspase dependent and independent cell death in na+ψve and NGF treated PC12 cells after glutamate induced exitotoxicity. Epitheor. Klin. Farmakol. Farmakokinet. 25 94–97.

    Not in our library

  151. 151.

    Pourzitaki C. Klagas I. Kanellos G. Kritis A. (2009 ). Calpaine mediated cell death in naive and NGF treated PC12 cells after glutamate induced exitotoxicity. Epitheor. Klin. Farmakol. Farmakokinet. 27 79–82.

    Not in our library

  152. 152.
    Mitochondrial calcium uniporter Mcu controls excitotoxicity and is transcriptionally repressed by neuroprotective nuclear calcium signals · 2013
    No notice
  153. 153.

    Radi R. Beckman J. S. Bush K. M. Freeman B. A. (1991a ). Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266 4244–4250.

    Not in our library

  154. 154.

    Radi R. Beckman J. S. Bush K. M. Freeman B. A. (1991b ). Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288 481–487

    Not in our library10.1016/0003-9861(91)90224-7

  155. 155.

    Radi R. Rodriguez M. Castro L. Telleri R. (1994 ). Inhibition of mitochondrial electron transport by peroxynitrite. Arch. Biochem. Biophys. 308 89–95

    Not in our library10.1006/abbi.1994.1013

  156. 156.

    Rahman S. Neuman R. S. (1996 ). Characterization of metabotropic glutamate receptor-mediated facilitation of N-methyl-D-aspartate depolarization of neocortical neurones. Br. J. Pharmacol. 117 675–683

    Not in our library10.1111/j.1476-5381.1996.tb15243.x

  157. 157.

    Reid C. A. Bekkers J. M. Clements J. D. (2003 ). Presynaptic Ca2+ channels: a functional patchwork. Trends Neurosci. 26 683–687

    Not in our library10.1016/j.tins.2003.10.003

  158. 158.

    Reynolds I. J. Hastings T. G. (1995 ). Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J. Neurosci. 15 3318–3327.

    Not in our library10.1523/jneurosci.15-05-03318.1995

  159. 159.

    Rossi D. J. Brady J. D. Mohr C. (2007 ). Astrocyte metabolism and signaling during brain ischemia. Nat. Neurosci. 10 1377–1386

    Not in our library10.1038/nn2004

  160. 160.

    Roth J. A. Feng L. Walowitz J. Browne R. W. (2000 ). Manganese-induced rat pheochromocytoma (PC12) cell death is independent of caspase activation. J. Neurosci. Res. 61 162–171

    Not in our library10.1002/1097-4547(20000715)61:2<162::aid-jnr7>3.0.co;2-g

  161. 161.

    Ruiz A. Matute C. Alberdi E. (2010 ). Intracellular Ca2+ release through ryanodine receptors contributes to AMPA receptor-mediated mitochondrial dysfunction and ER stress in oligodendrocytes. Cell Death Dis. 1:e54

    Not in our library10.1038/cddis.2010.31

  162. 162.

    Sadasivan S. Zhang Z. Larner S. F. Liu M. C. Zheng W. Kobeissy F. H. (2010 ). Acute NMDA toxicity in cultured rat cerebellar granule neurons is accompanied by autophagy induction and late onset autophagic cell death phenotype. BMC Neurosci. 11:21

    Not in our library10.1186/1471-2202-11-21

  163. 163.

    Said S. I. Dickman K. Dey R. D. Bandyopadhyay A. De Stefanis P. Raza S. (1998 ). Glutamate toxicity in the lung and neuronal cells: prevention or attenuation by VIP and PACAP. Ann. N. Y. Acad. Sci. 865 226–237

    Not in our library10.1111/j.1749-6632.1998.tb11182.x

  164. 164.

    Salgo M. G. Stone K. Squadrito G. L. Battista J. R. Pryor W. A. (1995 ). Peroxynitrite causes DNA nicks in plasmid pBR322. Biochem. Biophys. Res. Commun. 210 1025–1030

    Not in our library10.1006/bbrc.1995.1759

  165. 165.

    Salter M. W. (1998 ). Src, N-methyl-D-aspartate (n.d.) receptors, and synaptic plasticity. Biochem. Pharmacol. 56 789–798

    Not in our library10.1016/s0006-2952(98)00124-5

  166. 166.

    Sanchez-Gomez M. V. Alberdi E. Ibarretxe G. Torre I. Matute C. (2003 ). Caspase-dependent and caspase-independent oligodendrocyte death mediated by AMPA and kainate receptors. J. Neurosci. 23 9519–9528.

    Not in our library10.1523/jneurosci.23-29-09519.2003

  167. 167.

    Sandhu J. K. Pandey S. Ribecco-Lutkiewicz M. Monette R. Borowy-Borowski H. Walker P. R. (2003 ). Molecular mechanisms of glutamate neurotoxicity in mixed cultures of NT2-derived neurons and astrocytes: protective effects of coenzyme Q(10). J. Neurosci. Res. 72 691–703

    Not in our library10.1002/jnr.10579

  168. 168.

    Sandhu J. K. Sikorska M. Walker P. R. (2002 ). Characterization of astrocytes derived from human NTera-2/D1 embryonal carcinoma cells. J. Neurosci. Res. 68 604–614

    Not in our library10.1002/jnr.10236

  169. 169.

    Schrammel A. Gorren A. C. Schmidt K. Pfeiffer S. Mayer B. (2003 ). S-nitrosation of glutathione by nitric oxide, peroxynitrite, and (*)NO/O(2)(*-). Free Radic. Biol. Med. 34 1078–1088

    Not in our library10.1016/s0891-5849(03)00038-8

  170. 170.

    Schubert D. Kimura H. Maher P. (1992 ). Growth factors and vitamin E modify neuronal glutamate toxicity. Proc. Natl. Acad. Sci. U.S.A. 89 8264–8267

    Not in our library10.1073/pnas.89.17.8264

  171. 171.

    Seib T. M. Patel S. A. Bridges R. J. (2011 ). Regulation of the system x(C)- cystine/glutamate exchanger by intracellular glutathione levels in rat astrocyte primary cultures. Glia 59 1387–1401

    Not in our library10.1002/glia.21176

  172. 172.

    Sen N. Hara M. R. Ahmad A. S. Cascio M. B. Kamiya A. Ehmsen J. T. (2009 ). GOSPEL: a neuroprotective protein that binds to GAPDH upon S-nitrosylation. Neuron 63 81–91

    Not in our library10.1016/j.neuron.2009.05.024

  173. 173.

    Sen N. Hara M. R. Kornberg M. D. Cascio M. B. Bae B. I. Shahani N. (2008 ). Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis. Nat. Cell Biol. 10 866–873

    Not in our library10.1038/ncb1747

  174. 174.

    Shah S. A. Lee H. Y. Bressan R. A. Yun D. J. Kim M. O. (2014 ). Novel osmotin attenuates glutamate-induced synaptic dysfunction and neurodegeneration via the JNK/PI3K/Akt pathway in postnatal rat brain. Cell death dis. 5:e1026.

    Not in our library10.1038/cddis.2013.538

  175. 175.

    Shang L. Huang J. F. Ding W. Chen S. Xue L. X. Ma R. F. (2014 ). Calpain: a molecule to induce AIF-mediated necroptosis in RGC-5 following elevated hydrostatic pressure. BMC Neurosci. 15:63

    Not in our library10.1186/1471-2202-15-63

  176. 176.

    Shinohara Y. Nakajima Y. Nakanishi S. (2001 ). Glutamate induces focal adhesion kinase tyrosine phosphorylation and actin rearrangement in heterologous mGluR1-expressing CHO cells via calcium/calmodulin signaling. J. Neurochem. 78 365–373

    Not in our library10.1046/j.1471-4159.2001.00415.x

  177. 177.

    Singh J. Kaur G. (2009 ). Transcriptional regulation of PSA-NCAM expression by NMDA receptor activation in RA-differentiated C6 glioma cultures. Brain Res. Bull. 79 157–168

    Not in our library10.1016/j.brainresbull.2009.02.005

  178. 178.

    Skeberdis V. A. Lan J. Opitz T. Zheng X. Bennett M. V. Zukin R. S. (2001a ). mGluR1-mediated potentiation of NMDA receptors involves a rise in intracellular calcium and activation of protein kinase C. Neuropharmacology 40 856–865

    Not in our library10.1016/s0028-3908(01)00005-3

  179. 179.

    Skeberdis V. A. Lan J. Zheng X. Zukin R. S. Bennett M. V. (2001b ). Insulin promotes rapid delivery of N-methyl-D- aspartate receptors to the cell surface by exocytosis. Proc. Natl. Acad. Sci. U.S.A. 98 3561–3566

    Not in our library10.1073/pnas.051634698

  180. 180.

    Smialowska M. Golembiowska K. Kajta M. Zieba B. Dziubina A. Domin H. (2012 ). Selective mGluR1 antagonist EMQMCM inhibits the kainate-induced excitotoxicity in primary neuronal cultures and in the rat hippocampus. Neurotox. Res. 21 379–392

    Not in our library10.1007/s12640-011-9293-4

  181. 181.

    Sribnick E. A. Ray S. K. Banik N. L. (2006 ). Estrogen prevents glutamate-induced apoptosis in C6 glioma cells by a receptor-mediated mechanism. Neuroscience 137 197–209

    Not in our library10.1016/j.neuroscience.2005.08.074

  182. 182.

    Stanciu M. Wang Y. Kentor R. Burke N. Watkins S. Kress G. (2000 ). Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J. Biol. Chem. 275 12200–12206

    Not in our library10.1074/jbc.275.16.12200

  183. 183.

    Sucher N. J. Brose N. Deitcher D. L. Awobuluyi M. Gasic G. P. Bading H. (1993 ). Expression of endogenous NMDAR1 transcripts without receptor protein suggests post-transcriptional control in PC12 cells. J. Biol. Chem. 268 22299–22304.

    Not in our library

  184. 184.

    Suh H. W. Kang S. Kwon K. S. (2007 ). Curcumin attenuates glutamate-induced HT22 cell death by suppressing MAP kinase signaling. Mol. Cell. Biochem. 298 187–194

    Not in our library10.1007/s11010-006-9365-6

  185. 185.

    Sulkowski G. Dabrowska-Bouta B. Salinska E. Struzynska L. (2014 ). Modulation of glutamate transport and receptor binding by glutamate receptor antagonists in EAE rat brain. PLoS ONE 9:e113954

    Not in our library10.1371/journal.pone.0113954

  186. 186.

    Sun D. Murali S. G. (1998 ). Stimulation of Na+-K+-2Cl- cotransporter in neuronal cells by excitatory neurotransmitter glutamate. Am. J. Physiol. 275 C772–C779.

    Not in our library10.1152/ajpcell.1998.275.3.c772

  187. 187.

    Sun L. Gu L. Wang S. Yuan J. Yang H. Zhu J. (2012 ). N-acetylcysteine protects against apoptosis through modulation of group I metabotropic glutamate receptor activity. PLoS ONE 7:e32503

    Not in our library10.1371/journal.pone.0032503

  188. 188.

    Sun Z. W. Zhang L. Zhu S. J. Chen W. C. Mei B. (2010 ). Excitotoxicity effects of glutamate on human neuroblastoma SH-SY5Y cells via oxidative damage. Neurosci. Bull. 26 8–16

    Not in our library10.1007/s12264-010-0813-7

  189. 189.

    Susin S. A. Lorenzo H. K. Zamzami N. Marzo I. Snow B. E. Brothers G. M. (1999 ). Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397 441–446

    Not in our library10.1038/17135

  190. 190.

    Suyama K. Watanabe M. Sakabe K. Okada Y. Matsuyama D. Kuroiwa M. (2011 ). Overexpression of GRP78 protects glial cells from endoplasmic reticulum stress. Neurosci. Lett. 504 271–276

    Not in our library10.1016/j.neulet.2011.09.045

  191. 191.

    Szab C. (2003 ). Multiple pathways of peroxynitrite cytotoxicity. Toxicol. Lett. 140–141, 105–112

    Not in our library10.1016/s0378-4274(02)00507-6

  192. 192.

    Tan S. Schubert D. Maher P. (2001 ). Oxytosis: a novel form of programmed cell death. Curr. Top. Med. Chem. 1 497–506

    Not in our library10.2174/1568026013394741

  193. 193.

    Tan S. Wood M. Maher P. (1998 ). Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells. J. Neurochem. 71 95–105

    Not in our library10.1046/j.1471-4159.1998.71010095.x

  194. 194.

    Tchedre K. T. Yorio T. (2008 ). sigma-1 receptors protect RGC-5 cells from apoptosis by regulating intracellular calcium, Bax levels, and caspase-3 activation. Invest. Ophthalmol. Vis. Sci. 49 2577–2588

    Not in our library10.1167/iovs.07-1101

  195. 195.

    Terman A. Gustafsson B. Brunk U. T. (2006 ). The lysosomalGAϒ mitochondrial axis theory of postmitotic aging and cell death. Chem. Biol. Interact. 163 29–37

    Not in our library10.1016/j.cbi.2006.04.013

  196. 196.

    Thomas G. M. Huganir R. L. (2004 ). MAPK cascade signalling and synaptic plasticity. Nat. Rev. Neurosci. 5 173–183

    Not in our library10.1038/nrn1346

  197. 197.

    Tobaben S. Grohm J. Seiler A. Conrad M. Plesnila N. Culmsee C. (2011 ). Bid-mediated mitochondrial damage is a key mechanism in glutamate-induced oxidative stress and AIF-dependent cell death in immortalized HT-22 hippocampal neurons. Cell Death Differ. 18 282–292

    Not in our library10.1038/cdd.2010.92

  198. 198.

    Tsuchioka M. Hisaoka K. Yano R. Shibasaki C. Kajiatani N. Takebayashi M. (2011 ). Riluzole-induced glial cell line-derived neurotrophic factor production is regulated through fibroblast growth factor receptor signaling in rat C6 glioma cells. Brain Res. 1384 1–8

    Not in our library10.1016/j.brainres.2011.01.100

  199. 199.

    Tyurin V. A. Tyurina Y. Y. Quinn P. J. Schor N. F. Balachandran R. Day B. W. (1998 ). Glutamate-induced cytotoxicity in PC12 pheochromocytoma cells: role of oxidation of phospholipids, glutathione and protein sulfhydryls revealed by bcl-2 transfection. Brain Res. Mol.Brain Res. 60 270–281

    Not in our library10.1016/s0169-328x(98)00181-8

  200. 200.

    Ugolini A. Corsi M. Bordi F. (1997 ). Potentiation of NMDA and AMPA responses by group I mGluR in spinal cord motoneurons. Neuropharmacology 36 1047–1055

    Not in our library10.1016/s0028-3908(97)00103-2

  201. 201.

    Van Bergen N. J. Wood J. P. Chidlow G. Trounce I. A. Casson R. J. Ju W. K. (2009 ). Recharacterization of the RGC-5 retinal ganglion cell line. Invest. Ophthalmol. Vis. Sci. 50 4267–4272

    Not in our library10.1167/iovs.09-3484

  202. 202.

    Vazhappilly R. Sucher N. J. (2002 ). Turnover analysis of N-methyl-D-aspartate receptor subunit NR1 protein in PC12 cells. Neurosci. Lett. 318 153–157

    Not in our library10.1016/s0304-3940(01)02482-x

  203. 203.

    Vedia L. McDonald B. Reep B. Brune B. Di S. M. Billiar T. R. (1992 ). Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation. J. Biol. Chem. 267 24929–24932.

    Not in our library

  204. 204.

    Veenman L. Bode J. Gaitner M. Caballero B. Pe’er Y. Zeno S. (2012 ). Effects of 18-kDa translocator protein knockdown on gene expression of glutamate receptors, transporters, and metabolism, and on cell viability affected by glutamate. Pharmacogenet. Genomics 22 606–619

    Not in our library10.1097/fpc.0b013e3283544531

  205. 205.

    Verkhratsky A. (2005 ). Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons. Physiol. Rev. 85 201–279

    Not in our library10.1152/physrev.00004.2004

  206. 206.

    Villalba M. Bockaert J. Journot L. (1997 ). Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway. J. Neurosci. 17 83–90.

    Not in our library10.1523/jneurosci.17-01-00083.1997

  207. 207.

    Viwatpinyo K. Chongthammakun S. (2009 ). Activation of group I metabotropic glutamate receptors leads to brain-derived neurotrophic factor expression in rat C6 cells. Neurosci. Lett. 467 127–130

    Not in our library10.1016/j.neulet.2009.10.020

  208. 208.

    Voulgari-Kokota A. Fairless R. Karamita M. Kyrargyri V. Tseveleki V. Evangelidou M. (2012 ). Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function. Exp. Neurol. 236 161–170

    Not in our library10.1016/j.expneurol.2012.04.011

  209. 209.

    Wang Y. Qin Z. H. (2010 ). Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis 15 1382–1402

    Not in our library10.1007/s10495-010-0481-0

  210. 210.

    Xiang H. Kinoshita Y. Knudson C. M. Korsmeyer S. J. Schwartzkroin P. A. Morrison R. S. (1998 ). Bax involvement in p53-mediated neuronal cell death. J. Neurosci. 18 1363–1373.

    Not in our library10.1523/jneurosci.18-04-01363.1998

  211. 211.

    Xie H. R. Hu L. S. Li G. Y. (2010 ). SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson’s disease. Chin. Med. J. 123 1086–1092.

    Not in our library

  212. 212.

    Xu J. Kurup P. Zhang Y. Goebel-Goody S. M. Wu P. H. Hawasli A. H. (2009 ). Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP. J. Neurosci. 29 9330–9343

    Not in our library10.1523/jneurosci.2212-09.2009

  213. 213.

    Xu X. Chua C. C. Kong J. Kostrzewa R. M. Kumaraguru U. Hamdy R. C. (2007 ). Necrostatin-1 protects against glutamate-induced glutathione depletion and caspase-independent cell death in HT-22 cells. J. Neurochem. 103 2004–2014

    Not in our library10.1111/j.1471-4159.2007.04884.x

  214. 214.

    Xu X. Chua C. C. Zhang M. Geng D. Liu C. F. Hamdy R. C. (2010 ). The role of PARP activation in glutamate-induced necroptosis in HT-22 cells. Brain Res. 1343 206–212

    Not in our library10.1016/j.brainres.2010.04.080

  215. 215.

    Yamakura F. Taka H. Fujimura T. Murayama K. (1998 ). Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J. Biol. Chem. 273 14085–14089

    Not in our library10.1074/jbc.273.23.14085

  216. 216.

    Yamaya Y. Yoshioka A. Saiki S. Yuki N. Hirose G. Pleasure D. (2002 ). Type-2 astrocyte-like cells are more resistant than oligodendrocyte-like cells against non-N-methyl-D-aspartate glutamate receptor-mediated excitotoxicity. J. Neurosci. Res. 70 588–598

    Not in our library10.1002/jnr.10425

  217. 217.

    Yang J. L. Sykora P. Wilson D. M. III Mattson M. P. Bohr V. A. (2011 ). The excitatory neurotransmitter glutamate stimulates DNA repair to increase neuronal resiliency. Mech. Ageing Dev. 132 405–411

    Not in our library10.1016/j.mad.2011.06.005

  218. 218.

    Yang X. R. Sun P. Qin H. P. Si P. P. Sun X. F. Zhang C. (2012 ). Involvement of MAPK pathways in NMDA-induced apoptosis of rat cortical neurons. Sheng Li Xue Bao 64 609–616.

    Not in our library

  219. 219.

    Yazlovitskaya E. M. Pelling J. C. Persons D. L. (1999 ). Association of apoptosis with the inhibition of extracellular signal-regulated protein kinase activity in the tumor necrosis factor alpha-resistant ovarian carcinoma cell line UCI 101. Mol. Carcinog. 25 14–20

    Not in our library10.1002/(sici)1098-2744(199905)25:1<14::aid-mc2>3.0.co;2-v

  220. 220.

    Yoshioka A. Hardy M. Younkin D. P. Grinspan J. B. Stern J. L. Pleasure D. (1995 ). Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors mediate excitotoxicity in the oligodendroglial lineage. J. Neurochem. 64 2442–2448

    Not in our library10.1046/j.1471-4159.1995.64062442.x

  221. 221.

    Yoshioka A. Yamaya Y. Saiki S. Kanemoto M. Hirose G. Beesley J. (2000 ). Non-N-methyl-D-aspartate glutamate receptors mediate oxygen–glucose deprivation-induced oligodendroglial injury. Brain Res. 854 207–215

    Not in our library10.1016/s0006-8993(99)02359-8

  222. 222.

    Yoshioka A. Yudkoff M. Pleasure D. (1997 ). Expression of glutamic acid decarboxylase during human neuronal differentiation: studies using the NTera-2 culture system. Brain Res. 767 333–339

    Not in our library10.1016/s0006-8993(97)00627-6

  223. 223.

    Younkin D. P. Tang C. M. Hardy M. Reddy U. R. Shi Q. Y. Pleasure S. J. (1993 ). Inducible expression of neuronal glutamate receptor channels in the NT2 human cell line. Proc. Natl. Acad. Sci. U.S.A. 90 2174–2178

    Not in our library10.1073/pnas.90.6.2174

  224. 224.

    Yu Z. Luo H. Fu W. Mattson M. P. (1999 ). The endoplasmic reticulum stress-responsive protein GRP78 protects neurons against excitotoxicity and apoptosis: suppression of oxidative swtress and stabilization of calcium homeostasis. Exp. Neurol. 155 302–314

    Not in our library10.1006/exnr.1998.7002

  225. 225.

    Zaulyanov L. L. Green P. S. Simpkins J. W. (1999 ). Glutamate receptor requirement for neuronal death from anoxia-reoxygenation: an in Vitro model for assessment of the neuroprotective effects of estrogens. Cell. Mol. Neurobiol. 19 705–718

    Not in our library10.1023/a:1006948921855

  226. 226.
    Glutamate-induced apoptosis in neuronal cells is mediated via caspase-dependent and independent mechanisms involving calpain and caspase-3 proteases as well as apoptosis inducing factor (AIF) and this process is inhibited by equine estrogens · 2006
    No notice
  227. 227.

    Zhu J. W. Yuan J. F. Yang H. M. Wang S. T. Zhang C. G. Sun L. L. (2012 ). Extracellular cysteine (Cys)/cystine (CySS) redox regulates metabotropic glutamate receptor 5 activity. Biochimie 94 617–627

    Not in our library10.1016/j.biochi.2011.09.013

Cited by papers we hold 4

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.